<!DOCTYPE  html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"/><title>2 Principles of imaging</title><link href="navigation.css" rel="stylesheet" type="text/css"/><link href="document.css" rel="stylesheet" type="text/css"/></head><body><p class="top_nav"><a href="part7.htm">&lt; Назад</a><span> | </span><a href="../index.html">Содержимое</a><span> | </span><a href="part9.htm">Далее &gt;</a></p><p style="padding-top: 4pt;padding-left: 65pt;text-indent: 0pt;text-align: left;"><a href="#bookmark7" class="s17" name="bookmark35">Chapter 2</a><a name="bookmark36">&zwnj;</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 65pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="374" height="1" alt="image" src="Image_005.png"/></span></p><p style="padding-top: 4pt;padding-left: 65pt;text-indent: 0pt;text-align: left;"><h2 href="#bookmark7">Principles of imaging</h2></p><p class="s18" style="padding-top: 10pt;padding-left: 63pt;text-indent: 0pt;line-height: 111%;text-align: left;">Connie yip, n. Jane taylor, anthony Chambers, and Vicky Goh</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s19" style="padding-top: 12pt;padding-left: 21pt;text-indent: 0pt;text-align: left;">2.1 <span class="h4">Introduction</span></p><p style="padding-top: 4pt;padding-left: 21pt;text-indent: 0pt;line-height: 94%;text-align: justify;">Imaging is fundamentally important to the management of the cancer patient. Anatomical imaging is the mainstay for patient evaluation; however, molecular, func- tional, and hybrid (combined molecular/functional–anatomical) imaging have ac- quired an increasing role.</p><p style="padding-left: 21pt;text-indent: 8pt;line-height: 94%;text-align: justify;">To obtain the most accurate and reliable information possible with the most appro- priate imaging modality the relative performance of the imaging test has to be defined. Commonly used measures of test performance include:</p><p class="s23" style="padding-top: 2pt;padding-left: 33pt;text-indent: -11pt;line-height: 94%;text-align: left;">◆ <span class="s12">Sensitivity</span><span class="p">: how good the test is at picking up disease (true positive (TP)/TP + false negative (FN)), expressed as a percentage.</span></p><p class="s23" style="padding-top: 2pt;padding-left: 33pt;text-indent: -11pt;line-height: 94%;text-align: left;">◆ <span class="s12">Specificity</span><span class="p">: how good the test is at excluding disease (true negative (TN)/TN + false positive (FP)), expressed as a percentage.</span></p><p class="s23" style="padding-top: 2pt;padding-left: 33pt;text-indent: -11pt;line-height: 94%;text-align: left;">◆ <span class="s12">Accuracy</span><span class="p">: how good a test is at picking up and excluding disease (TP + TN/TP + FP + TN + FN), expressed as a percentage.</span></p><p style="padding-top: 2pt;padding-left: 21pt;text-indent: 0pt;line-height: 94%;text-align: justify;">Test performance is also affected by the prevalence of disease in the population: test performance will be lower if disease prevalence in the population is low, that is, the <i>positive predictive value </i>(TP/TP + FP) will be lower (Table 2.1). Other parameters that have been used include receiver operator curve (ROC) analysis, frequency of manage- ment change, and cost-benefit analysis.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s19" style="padding-left: 21pt;text-indent: 0pt;text-align: left;">2.2 <span class="h4">X-ray</span></p><p style="padding-top: 4pt;padding-left: 21pt;text-indent: 0pt;line-height: 94%;text-align: justify;">X-ray remains an important part of cancer management, for example for suspected lung cancer. Although it has poor sensitivity and specificity, it is widely available and cheap. Digital systems which have replaced conventional films have the advantage that images can be viewed and distributed with a higher patient throughput. Digital de- tectors also demonstrate increased dose efficiency and a greater dynamic range, po- tentially reducing radiation exposure to the patient.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s24" style="padding-top: 5pt;padding-left: 51pt;text-indent: 0pt;line-height: 117%;text-align: left;">Table 2.1 <span class="s25">effect of disease prevalence on the performance of a test with 90% sensitivity and 90% specificity in the population imaged (1000 independent tests)</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><table style="border-collapse:collapse;margin-left:51.3407pt" cellspacing="0"><tr style="height:24pt"><td style="width:61pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s26" style="padding-top: 1pt;padding-right: 7pt;text-indent: 0pt;line-height: 112%;text-align: left;">Disease prevalence (%)</p></td><td style="width:51pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s26" style="padding-top: 1pt;padding-left: 7pt;text-indent: 0pt;line-height: 112%;text-align: left;">True positives</p></td><td style="width:54pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s26" style="padding-top: 1pt;padding-left: 11pt;text-indent: 0pt;line-height: 112%;text-align: left;">False positives</p></td><td style="width:86pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s26" style="padding-top: 1pt;padding-left: 10pt;padding-right: 9pt;text-indent: 0pt;line-height: 112%;text-align: left;">Positive predictive value (%)</p></td></tr><tr style="height:15pt"><td style="width:61pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">75</p></td><td style="width:51pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">675</p></td><td style="width:54pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">25</p></td><td style="width:86pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 10pt;text-indent: 0pt;text-align: left;">96</p></td></tr><tr style="height:15pt"><td style="width:61pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">50</p></td><td style="width:51pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">450</p></td><td style="width:54pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">50</p></td><td style="width:86pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 10pt;text-indent: 0pt;text-align: left;">90</p></td></tr><tr style="height:15pt"><td style="width:61pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10</p></td><td style="width:51pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">90</p></td><td style="width:54pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">90</p></td><td style="width:86pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 10pt;text-indent: 0pt;text-align: left;">50</p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s28" style="padding-left: 15pt;text-indent: 0pt;text-align: left;">2.2.1 <span class="s29">Production of X-rays</span></p><p style="padding-top: 3pt;padding-left: 15pt;text-indent: 0pt;line-height: 94%;text-align: justify;">X-rays are produced from an X-ray tube, a glass envelope vacuum with a wire element at one end forming the cathode, and a heavy metal target (e.g. tungsten or copper) at the other end forming the anode. Application of a high voltage at the cathode results in the formation of electrons which are drawn towards the anode. Collision with the heavy metal target produces X-rays.</p><p class="s28" style="padding-top: 10pt;padding-left: 15pt;text-indent: 0pt;text-align: left;">2.2.2 <span class="s29">X-ray quality and intensity</span></p><p class="s12" style="padding-top: 3pt;padding-left: 15pt;text-indent: 0pt;line-height: 94%;text-align: justify;">Quality <span class="p">describes the penetrating power of an X-ray beam. </span>Intensity <span class="p">describes the quantity of radiation energy flowing in unit time. In practice an X-ray beam consists of a continuous spectrum of energies up to a maximum determined by the voltage ap- plied between the cathode and the anode, for example a voltage setting of 120 kV will produce a range of X-ray energies up to a maximum of 120 keV.</span></p><p style="padding-left: 24pt;text-indent: 0pt;line-height: 12pt;text-align: justify;">Factors affecting X-ray tube output include:</p><p class="s23" style="padding-top: 2pt;padding-left: 27pt;text-indent: -11pt;line-height: 94%;text-align: justify;">◆ <span class="s12">Tube kilovoltage</span><span class="p">: this affects both beam quality and intensity. The higher the kV, the greater the beam penetration: settings ranging from 28 kV to 30 kV are used for mammography, and 70–90 kV for body imaging.</span></p><p class="s23" style="padding-top: 2pt;padding-left: 27pt;text-indent: -11pt;line-height: 94%;text-align: justify;">◆ <span class="s12">Tube current</span><span class="p">: this affects beam intensity only. In general, beam intensity is directly proportional to tube current.</span></p><p class="s23" style="padding-top: 2pt;padding-left: 27pt;text-indent: -11pt;line-height: 94%;text-align: justify;">◆ <span class="s12">Beam filtration</span><span class="p">: filters are placed into the X-ray beam to improve beam quality by absorbing lower energy radiation, yet transmitting higher energy X-rays. Typical filters include aluminium, copper, molybdenum, or palladium.</span></p><p class="s23" style="padding-top: 2pt;padding-left: 27pt;text-indent: -11pt;line-height: 94%;text-align: justify;">◆ <span class="s12">Distance from source</span><span class="p">: an X-ray tube produces a diverging beam, subject to a reduc- tion in intensity with distance obeying the inverse square law.</span></p><p class="s23" style="padding-top: 2pt;padding-left: 27pt;text-indent: -11pt;line-height: 94%;text-align: justify;">◆ <span class="s12">Tube target material</span><span class="p">: the proton number of the target affects the intensity of the beam produced. Beam quality is not affected.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s28" style="padding-left: 15pt;text-indent: 0pt;text-align: left;">2.2.3 <span class="s29">Interaction of X-ray with matter</span></p><p style="padding-top: 3pt;padding-left: 15pt;text-indent: 0pt;line-height: 94%;text-align: justify;">There are two main types of interaction between X-ray and matter at the photon ener- gies produced for diagnostic radiology:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s23" style="padding-top: 5pt;padding-left: 33pt;text-indent: -11pt;line-height: 94%;text-align: justify;">◆ <span class="s12">Photoelectric effect</span><span class="p">: the interaction of X-ray photons with tightly bound electrons which absorb all the energy of the X-ray photon. The electrons are then ejected from the atom, a ‘photoelectron’. Photoelectric interactions occur at lower energies (&lt;1 MeV) and predominate in the diagnostic energy range. The degree of absorp- tion is highly dependent upon the atomic number of the tissue.</span></p><p class="s23" style="padding-top: 2pt;padding-left: 33pt;text-indent: -11pt;line-height: 94%;text-align: justify;">◆ <span class="s12">Compton scattering</span><span class="p">: the interaction of X-ray photons with loosely bound orbital electrons. The X-ray photons lose some energy and are deflected or scattered; this interaction predominates in the megavoltage energy ranges used for therapeutic radiation beams. The probability of interaction is independent of atomic number and varies with tissue electron density.</span></p><p style="padding-top: 2pt;padding-left: 21pt;text-indent: 0pt;line-height: 94%;text-align: justify;">Different tissues in the body attenuate X-rays differently. Tube voltages between 20 kV and 65 kV provide the best contrast for body imaging, with excellent differentiation between soft tissue and bone as the photoelectric effect is dominant. At higher energies, when the Compton effect dominates, image contrast is predominantly due to tissue density.</p><p class="s28" style="padding-top: 10pt;padding-left: 21pt;text-indent: 0pt;text-align: left;">2.2.4 <span class="s29">Image generation and processing</span></p><p style="padding-top: 3pt;padding-left: 21pt;text-indent: 0pt;line-height: 94%;text-align: justify;">Digital images consist of picture elements or <i>pixels</i>; the 2D representation of pixels in an image is called the <i>matrix</i>. Following exposure of digital detectors to X-rays, the energy absorbed is transformed into electric charges, which are then processed into a greyscale clinical image representing the amount of energy deposited. A digital header file containing patient information is added to the image generated.</p><p style="padding-left: 29pt;text-indent: 0pt;line-height: 12pt;text-align: justify;">The following factors influence image quality:</p><p class="s23" style="padding-top: 2pt;padding-left: 33pt;text-indent: -11pt;line-height: 94%;text-align: justify;">◆ <span class="s12">Spatial resolution</span><span class="p">: in digital radiography, spatial resolution (the minimal resolvable separation of two high-contrast objects) is defined by minimum pixel size. This is in the order of 100–200 microns. The use of direct conversion detectors increases spatial resolution as the scatter of X-ray quanta and light photons within the de- tector influences spatial resolution.</span></p><p class="s23" style="padding-top: 2pt;padding-left: 33pt;text-indent: -11pt;line-height: 94%;text-align: justify;">◆ <span class="s12">Dynamic range</span><span class="p">: this refers to the range of X-ray exposures over which a meaningful image can be obtained. Digital detectors have a wide and linear dynamic range in comparison to previously used screen-film combinations, so that differences in specific tissue absorption (e.g. bone versus soft tissue) can be displayed in a single image without the need for additional imaging.</span></p><p class="s23" style="padding-top: 2pt;padding-left: 33pt;text-indent: -11pt;line-height: 94%;text-align: justify;">◆ <span class="s12">Detective quantum efficiency</span><span class="p">: this refers to the efficiency of a detector in converting X-ray energy into an image signal. It is dependent on radiation exposure, radi- ation quality, spatial frequency, modulation transfer function (the capacity of the detector to transfer the modulation of input signal at a given spatial frequency to its output), and detector material.</span></p><p style="padding-top: 2pt;padding-left: 21pt;text-indent: 0pt;line-height: 94%;text-align: justify;">Post-processing is performed following exposure and readout to ensure images are optimized for viewing (Figure 2.1). Spatial resolution is dependent on the detector and cannot be altered by post-processing; however, manoeuvres including contrast optimization, noise reduction, and artefact removal can compensate for poorer spatial resolution. Different algorithms are generally applied to different anatomic regions in order to prevent inadvertent suppression of useful information.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="text-indent: 0pt;text-align: left;"><span><img width="400" height="169" alt="image" src="Image_006.gif"/></span></p><p class="s30" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(a)</p><p class="s30" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(a)</p><p style="text-indent: 0pt;text-align: left;"/><p class="s30" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(a)</p><p class="s30" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(b)</p><p class="s30" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(b)</p><p style="text-indent: 0pt;text-align: left;"/><p class="s30" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(b)</p><p class="s30" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(c)</p><p class="s30" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(c)</p><p style="text-indent: 0pt;text-align: left;"/><p class="s30" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(c)</p><p class="s24" style="padding-top: 4pt;padding-left: 15pt;text-indent: 0pt;line-height: 117%;text-align: left;">Fig. 2.1 <span class="s25">digital radiographs: images can be digitally processed to alter image quality. the effect of contrast enhancement (a), contrast reduction (b), and edge enhancement</span></p><p class="s25" style="padding-left: 15pt;text-indent: 0pt;line-height: 10pt;text-align: left;">(c) is shown.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s19" style="padding-top: 5pt;padding-left: 15pt;text-indent: 0pt;text-align: left;">2.3 <span class="h4">Computed tomography</span></p><p style="padding-top: 4pt;padding-left: 15pt;text-indent: 0pt;line-height: 94%;text-align: justify;">CT is currently the most widely used imaging modality for cancer imaging. Since its introduction in 1971, CT technology has evolved rapidly. In general it is a sensitive and specific test, though values vary depending on the body part examined.</p><p class="s28" style="padding-top: 10pt;padding-left: 15pt;text-indent: 0pt;text-align: left;">2.3.1 <span class="s29">Basic principles</span></p><p style="padding-top: 3pt;padding-left: 15pt;text-indent: 0pt;line-height: 94%;text-align: justify;">CT is an <i>X-ray tomographic technique </i>that provides non-superimposed cross- sectional images of the body. As the X-ray tube rotates around the patient, the X-ray beam passes through an axial section of the patient’s body from different directions. Detectors around the patient measure the intensity of the attenuated radiation beam as it emerges from the body. Detectors convert the X-ray intensity into electric sig- nals which are amplified and processed to compensate for inhomogeneities in the de- tector system and to correct for beam hardening effects. Data are then transformed into X-ray attenuation values producing the CT raw data. These are then reconstructed mathematically to yield the image dataset, for example using <i>filtered back projection</i>. Different <i>convolution kernels </i>can be applied enabling different types of images to be obtained (e.g. soft, smooth, sharp, edge enhanced). More recently, with the increasing use of low dose CT, advances in scanner hardware and increasing computing power, <i>iterative reconstruction </i>techniques are replacing <i>filtered back projection </i>to improve image noise and image characteristics.</p><p style="padding-left: 24pt;text-indent: 0pt;line-height: 11pt;text-align: justify;">During image reconstruction a <i>CT number </i>(Hounsfield unit) is assigned according</p><p style="padding-left: 15pt;text-indent: 0pt;line-height: 12pt;text-align: justify;">to the degree of attenuation. This is defined as:</p><p class="s32" style="padding-top: 8pt;padding-left: 20pt;text-indent: 0pt;text-align: center;"><span class="s31">CT = 1000 </span><span class="s33"> </span><span class="s31">(</span><span class="s33"> </span><span class="s33"> </span><span class="s34">water </span><span class="s35">)/</span><span class="s34">water</span></p><p style="padding-top: 7pt;padding-left: 15pt;text-indent: 0pt;line-height: 94%;text-align: justify;">A CT number of -1000 represents air, 0 represents water, around 50 represents soft tissue, and &gt;1000 represents cortical bone. There is no upper limit. Images are dis- played as a greyscale image. The resulting CT image is composed of a square matrix ranging in size from 256 × 256 to 1024 × 1024 pixel elements. Each pixel represents</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 5pt;padding-left: 21pt;text-indent: 0pt;line-height: 94%;text-align: justify;">a scanned voxel, each with its own CT number. Axial CT images can be manipulated further to produce reformatted images in any secondary plane and 3D images.</p><p class="s28" style="padding-top: 10pt;padding-left: 21pt;text-indent: 0pt;text-align: left;">2.3.2 <span class="s29">Computed tomography acquisition</span></p><p style="padding-top: 3pt;padding-left: 21pt;text-indent: 0pt;line-height: 94%;text-align: justify;">CT is currently based on helical CT, which was made possible by the introduction of slip ring technology allowing for a continuously rotating CT gantry. Images are ac- quired using the continuously rotating X-ray tube by moving the table top on which the patient lies through the scan plane. This results in a helical scan pattern and ac- quisition of a data volume. Because of the helical acquisition, <i>interpolation </i>has to be performed during image reconstruction to generate a planar dataset for each table position and to produce artefact-free images. Images can be generated from any seg- ment within the scanned volume by overlapping reconstructions as often as required. Different reconstruction intervals (spacing between sections) and section collimations (section thickness) can be used.</p><p style="padding-left: 21pt;text-indent: 8pt;line-height: 94%;text-align: justify;">Multidetector helical CT, introduced in 1998, has resulted in a large gain in CT per- formance, including a shorter acquisition duration, longer scan ranges, and thinner sections with near isotropic resolution. Multidetector helical CT uses the radiation de- livered more efficiently. The number of detector rows currently stands at 320 for state- of-the-art scanners. Dual-source CT with two X-ray tubes and two corresponding multidetector arrays has also been developed. The acquisition systems are mounted on a rotating gantry with a 90° angular offset. The gantry rotation time is &lt;0.3 s, and dual- source CT can provide temporal resolutions one-quarter of the gantry rotation time.</p><p style="padding-left: 21pt;text-indent: 8pt;line-height: 94%;text-align: justify;">Typical acquisition parameters for general imaging of the thorax, abdomen, and pelvis are summarized in Table 2.2.</p><p class="s23" style="padding-top: 3pt;padding-left: 33pt;text-indent: -11pt;line-height: 94%;text-align: justify;">◆ <span class="s12">Kilovoltage (kV)</span><span class="p">: typically 120 kV is applied for diagnostic body imaging, although more recently kV modulation is possible according to patient habitus. Dual-energy imaging is performed on a dual-source CT using two different kV, for example 140 kV and 100 kV with beam filtration.</span></p><p class="s24" style="padding-top: 11pt;padding-left: 21pt;text-indent: 0pt;text-align: justify;">Table 2.2 <span class="s25">typical Ct acquisition parameters for multidetector Ct (64 rows and above)</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><table style="border-collapse:collapse;margin-left:21.3387pt" cellspacing="0"><tr style="height:14pt"><td style="width:108pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:82pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s26" style="padding-top: 1pt;padding-left: 3pt;text-indent: 0pt;text-align: left;">Thorax</p></td><td style="width:69pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s26" style="padding-top: 1pt;padding-left: 4pt;text-indent: 0pt;text-align: left;">Abdomen</p></td><td style="width:64pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s26" style="padding-top: 1pt;padding-left: 3pt;text-indent: 0pt;text-align: left;">Pelvis</p></td></tr><tr style="height:26pt"><td style="width:108pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Positioning</p></td><td style="width:82pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 3pt;padding-right: 4pt;text-indent: 0pt;line-height: 112%;text-align: left;">thoracic inlet to below diaphragm</p></td><td style="width:69pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 4pt;text-indent: 0pt;line-height: 112%;text-align: left;">above diaphragm to iliac crest</p></td><td style="width:64pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 3pt;text-indent: 0pt;line-height: 112%;text-align: left;">Iliac crest to symphysis pubis</p></td></tr><tr style="height:15pt"><td style="width:108pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">kV</p></td><td style="width:82pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 3pt;text-indent: 0pt;text-align: left;">120</p></td><td style="width:69pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 4pt;text-indent: 0pt;text-align: left;">120</p></td><td style="width:64pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 3pt;text-indent: 0pt;text-align: left;">120</p></td></tr><tr style="height:15pt"><td style="width:108pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">effective mas</p></td><td style="width:82pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 3pt;text-indent: 0pt;text-align: left;">200</p></td><td style="width:69pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 4pt;text-indent: 0pt;text-align: left;">280</p></td><td style="width:64pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 3pt;text-indent: 0pt;text-align: left;">300</p></td></tr><tr style="height:15pt"><td style="width:108pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Pitch</p></td><td style="width:82pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 3pt;text-indent: 0pt;text-align: left;">0.75</p></td><td style="width:69pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 4pt;text-indent: 0pt;text-align: left;">0.75</p></td><td style="width:64pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 3pt;text-indent: 0pt;text-align: left;">0.75</p></td></tr><tr style="height:15pt"><td style="width:108pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">detector collimation (mm)</p></td><td style="width:82pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 3pt;text-indent: 0pt;text-align: left;">0.6</p></td><td style="width:69pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 4pt;text-indent: 0pt;text-align: left;">0.6</p></td><td style="width:64pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 3pt;text-indent: 0pt;text-align: left;">0.6</p></td></tr><tr style="height:15pt"><td style="width:108pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">reconstruction increment (mm)</p></td><td style="width:82pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 3pt;text-indent: 0pt;text-align: left;">3–5</p></td><td style="width:69pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 4pt;text-indent: 0pt;text-align: left;">3–5</p></td><td style="width:64pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 3pt;text-indent: 0pt;text-align: left;">3–5</p></td></tr><tr style="height:26pt"><td style="width:108pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">reconstruction kernel</p></td><td style="width:82pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 3pt;text-indent: 0pt;line-height: 112%;text-align: left;">B30f medium smooth and B80f ultra sharp</p></td><td style="width:69pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 4pt;text-indent: 0pt;line-height: 112%;text-align: left;">B30f medium smooth</p></td><td style="width:64pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 3pt;text-indent: 0pt;line-height: 112%;text-align: left;">B30f medium smooth</p></td></tr><tr style="height:15pt"><td style="width:108pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">effective slice collimation (mm)</p></td><td style="width:82pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 3pt;text-indent: 0pt;text-align: left;">3–5</p></td><td style="width:69pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 4pt;text-indent: 0pt;text-align: left;">3–5</p></td><td style="width:64pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 3pt;text-indent: 0pt;text-align: left;">3–5</p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s12" style="padding-top: 5pt;padding-left: 27pt;text-indent: -11pt;line-height: 94%;text-align: justify;"><span class="s23">◆  </span>Milliampere second (mAs)<span class="p">: this is the product of the tube current (e.g. 200 mA) and rotation time of the scanner (e.g. 0.6 s). With multidetector CT this is often quoted as </span>effective mAs <span class="p">which is the product of the tube current and exposure time of one slice (rotation × collimation/feed per rotation). The mAs applied will depend on the body part examined. A higher mAs generally reduces image noise, thus improving the detectability of low-contrast structures, but has to be tempered by patient dose considerations. Current scanners use dose modulation techniques to reduce patient radiation exposure: the dose during each tube rotation is measured and altered depending on the attenuation level, making it possible to reduce the dose by as much as 56%.</span></p><p class="s23" style="padding-top: 4pt;padding-left: 27pt;text-indent: -11pt;line-height: 94%;text-align: justify;">◆ <span class="s12">Collimation</span><span class="p">: the radiation beam emitted by the X-ray tube can be shaped using special diaphragms or ‘collimators’ positioned either directly in front of the X-ray source (to shape the emitted beam) or directly in front of the detectors (to reduce the effect of scattered radiation). The collimation and focal spot size determines the quality of the slice profile. Images can be reconstructed with slice thicknesses equal to or greater than the detector collimation.</span></p><p class="s23" style="padding-top: 4pt;padding-left: 27pt;text-indent: -11pt;line-height: 94%;text-align: justify;">◆ <span class="s12">Increment</span><span class="p">: the distance between images reconstructed from a data volume. This should be selected as an overlapping increment to lower noise and improve image quality. An overlap of up to 90% can be achieved but an overlap of 30–50% is gen- erally used in clinical practice. For example, if slice thicknesses of 10 mm are recon- structed with a 5 mm increment, slices will overlap by 50%.</span></p><p class="s23" style="padding-top: 4pt;padding-left: 27pt;text-indent: -11pt;line-height: 94%;text-align: justify;">◆ <span class="s12">Pitch</span><span class="p">: this traditionally refers to table feed per rotation/collimation for single-slice CT. For multidetector CT, pitch is more complicated. Its value will depend on whether a single section collimation or total collimation of the detector array is used. Good image quality is obtained with a pitch between 1 and 2, defined as table feed per rotation/single section collimation.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s28" style="padding-left: 15pt;text-indent: 0pt;text-align: left;">2.3.3 <span class="s29">Image processing</span></p><p style="padding-top: 3pt;padding-left: 15pt;text-indent: 0pt;line-height: 94%;text-align: justify;">Multiplanar reformations (MPRs) are 2D reformatted images that are reconstructed secondarily from a stack of axial images, for example in the sagittal or coronal plane. Oblique and curved reformations can also be obtained but require interpolation be- tween adjacent voxels. Curved reformations are needed for structures that pass through multiple axial planes, for example blood vessels and bronchi. Isotropic imaging is ideal for good quality MPRs. MPRs are generally the width of one voxel but can be pro- duced with a greater section thickness to reduce image noise and further improve image quality. An example is shown in Figure 2.2.</p><p style="padding-left: 15pt;text-indent: 8pt;line-height: 94%;text-align: justify;">Maximum (MIP) and minimum intensity projections (MinIP) are volume ren- dering techniques. Images are generated by displaying the maximum or minimum CT numbers encountered along the direction of the projection, known as the viewing angle. This ensures that contrast is optimized between high-contrast structures and surrounding tissue.</p><p style="padding-left: 15pt;text-indent: 8pt;line-height: 94%;text-align: justify;">MIP views are generally used for CT angiography and for specialized pulmonary studies. MinIP images are used mainly for visualizing the central tracheobronchial</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 47pt;text-indent: 0pt;text-align: left;"><span><img width="360" height="358" alt="image" src="Image_007.gif"/></span></p><p class="s24" style="padding-top: 4pt;padding-left: 21pt;text-indent: 0pt;line-height: 117%;text-align: left;">Fig. 2.2 <span class="s25">Ct Images of the thorax: multiplanar reformats can be obtained from manipulating the original data set, in this case demonstrating a lung tumour causing superior vena cava obstruction.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 5pt;padding-left: 21pt;text-indent: 0pt;line-height: 94%;text-align: justify;">system. Volume rendering techniques have become the standard technique for CT angiography and for musculoskeletal imaging. Virtual colonography is a special type of volume rendered dataset giving a perspective view of ‘flying through’ the colon.</p><p class="s28" style="padding-top: 10pt;padding-left: 21pt;text-indent: 0pt;text-align: left;">2.3.4 <span class="s29">Radiation dose</span></p><p style="padding-top: 3pt;padding-left: 21pt;text-indent: 0pt;line-height: 94%;text-align: justify;">Radiation exposure in CT is dependent on scan parameters, scanner, and patient char- acteristics. Radiation dose with CT is generally 5–10× higher than corresponding con- ventional radiography, hence the importance of the ALARA (As Low As Reasonably Achievable) principle in ensuring that the patient receives the lowest possible radi- ation dose without compromising diagnostic scan quality.</p><p style="padding-left: 21pt;text-indent: 8pt;line-height: 87%;text-align: justify;">Parameters that are commonly used to describe dose are the volume CT dose index (CTDI<span class="s36">vol</span>), the total scan dose (dose length product, DLP), and radiation risk (effective dose).</p><p class="s23" style="padding-top: 2pt;padding-left: 33pt;text-indent: -11pt;line-height: 89%;text-align: justify;">◆ <span class="s12">CTDI</span><span class="s37">vol</span><span class="p">: this is the average local dose delivered to a phantom cross-section (in milliGray, mGy) and indicates the average local dose delivered to the patient. CTDI will underestimate the dose for children and slim patients, and overestimate this for obese patients.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s23" style="padding-top: 5pt;padding-left: 27pt;text-indent: -11pt;line-height: 94%;text-align: justify;">◆ <span class="s12">DLP</span><span class="p">: this is a measure of the cumulative dose delivered to the patient (in mGy.cm). It takes into account the average dose in the scan volume and the scan length (L).</span></p><p class="s31" style="padding-top: 10pt;padding-left: 21pt;text-indent: 0pt;text-align: center;">DLP = CTDI<span class="s38">vol </span><span class="s32"></span><span class="s33"> </span>L</p><p class="s23" style="padding-top: 9pt;padding-left: 27pt;text-indent: -11pt;line-height: 94%;text-align: justify;">◆ <span class="s12">Effective dose</span><span class="p">: this is an estimate of the radiation risk to patients (in millisieverts, mSv). Mathematical modelling is used to calculate effective dose appropriately weighted for individual organs for a standard male or female (of 70 kg). Again such estimates of E will underestimate the dose for children and slim patients, and over- estimate it for obese patients.</span></p><p style="padding-top: 2pt;padding-left: 15pt;text-indent: 0pt;line-height: 12pt;text-align: justify;">The European guidelines for quality in CT<span class="s22">1 </span>and UK national reference doses for CT (2003)<span class="s22">2 </span>provide reference doses for CT, indicating the CTDI<span class="s36">vol </span>and DLP that should not be exceeded (Table 2.3). The risk of death from radiation-induced cancer has been calculated from BEIR V and IRCP 60 data which extrapolate the risk estimates from accidentally or occupationally exposed groups, therefore reflecting high doses. The risk from diagnostic radiology (much lower doses) has to be extrapolated. The radiation- induced risk of death is approximately 0.5/10,000 persons, while the risk of fatal cancer is 3000/10,000 persons. The radiation-induced risk is age dependent (Table 2.4).</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s19" style="padding-left: 15pt;text-indent: 0pt;text-align: left;">2.4 <span class="h4">Ultrasound</span></p><p style="padding-top: 4pt;padding-left: 15pt;text-indent: 0pt;line-height: 94%;text-align: justify;">US remains one of the most widely used imaging modalities worldwide as it offers real- time imaging, is inexpensive, safe, and portable. In general it has moderate sensitivity and specificity. High-frequency sound beams (usually &gt;20 kHz) are used to generate high-resolution anatomical imaging. Modern US equipment still uses a pulse echo ap- proach with a brightness mode (B-mode) display but performance has been improved by the introduction of tissue harmonic imaging, extended field of view imaging, coded pulse excitation, and electronic section focusing; 3D and 4D imaging is also possible. US can also provide functional information, for example assessment of tissue regional perfusion using Doppler or contrast-enhanced US.</p><p class="s28" style="padding-top: 10pt;padding-left: 15pt;text-indent: 0pt;text-align: left;">2.4.1 <span class="s29">Basic principles</span></p><p style="padding-top: 3pt;padding-left: 15pt;text-indent: 0pt;line-height: 94%;text-align: justify;">US pulses are generated by an US transducer made from piezoelectric crystals. As an alternating electric voltage is applied, the crystal changes thickness and vibrates,</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s24" style="padding-left: 61pt;text-indent: 0pt;line-height: 117%;text-align: left;">Table 2.3 <span class="s25">national reference dose levels for multi-slice Ct as indicated by uK 2003 national dose review</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><table style="border-collapse:collapse;margin-left:61.3642pt" cellspacing="0"><tr style="height:14pt"><td style="width:82pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s26" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">Body part</p></td><td style="width:74pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s26" style="padding-top: 1pt;padding-left: 12pt;text-indent: 0pt;text-align: left;">CTDIvol (mGy)</p></td><td style="width:75pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s26" style="padding-top: 1pt;padding-left: 12pt;text-indent: 0pt;text-align: left;">DLP (mGy/cm)</p></td></tr><tr style="height:15pt"><td style="width:82pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Brain</p></td><td style="width:74pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 12pt;text-indent: 0pt;text-align: left;">65</p></td><td style="width:75pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 12pt;text-indent: 0pt;text-align: left;">930</p></td></tr><tr style="height:15pt"><td style="width:82pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Chest</p></td><td style="width:74pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 12pt;text-indent: 0pt;text-align: left;">13</p></td><td style="width:75pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 12pt;text-indent: 0pt;text-align: left;">580</p></td></tr><tr style="height:15pt"><td style="width:82pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">abdomen</p></td><td style="width:74pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 12pt;text-indent: 0pt;text-align: left;">14</p></td><td style="width:75pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 12pt;text-indent: 0pt;text-align: left;">470</p></td></tr><tr style="height:15pt"><td style="width:82pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">abdomen and pelvis</p></td><td style="width:74pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 12pt;text-indent: 0pt;text-align: left;">14</p></td><td style="width:75pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 12pt;text-indent: 0pt;text-align: left;">560</p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s24" style="padding-top: 5pt;padding-left: 93pt;text-indent: 0pt;line-height: 117%;text-align: left;">Table 2.4 <span class="s25">Calculated radiation-induced risk of dying from cancer (ICrP 60)</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><table style="border-collapse:collapse;margin-left:93.2305pt" cellspacing="0"><tr style="height:14pt"><td style="width:65pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s26" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">Age (years)</p></td><td style="width:114pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s26" style="padding-top: 1pt;padding-left: 24pt;text-indent: 0pt;text-align: left;">Risk (death per mSv)</p></td></tr><tr style="height:15pt"><td style="width:65pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">0–10</p></td><td style="width:114pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 24pt;text-indent: 0pt;text-align: left;">14/100,000</p></td></tr><tr style="height:15pt"><td style="width:65pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10–20</p></td><td style="width:114pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 24pt;text-indent: 0pt;text-align: left;">18/100,000</p></td></tr><tr style="height:15pt"><td style="width:65pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">20–30</p></td><td style="width:114pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 24pt;text-indent: 0pt;text-align: left;">7.5/100,000</p></td></tr><tr style="height:15pt"><td style="width:65pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">30–40</p></td><td style="width:114pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 24pt;text-indent: 0pt;text-align: left;">3.5/100,000</p></td></tr><tr style="height:15pt"><td style="width:65pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">60</p></td><td style="width:114pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 24pt;text-indent: 0pt;text-align: left;">2.0/100,000</p></td></tr><tr style="height:15pt"><td style="width:65pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">80</p></td><td style="width:114pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 24pt;text-indent: 0pt;text-align: left;">1.0/100,000</p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 21pt;text-indent: 0pt;line-height: 94%;text-align: justify;">generating a <i>mechanical wave</i>. These mechanical waves range in frequency of 2–15 MHz, travelling through biologic tissue at a velocity dependent upon the medium through which it is travelling. Sound travels more rapidly through tissues which dem- onstrate medium density and elasticity.</p><p style="padding-left: 21pt;text-indent: 8pt;line-height: 94%;text-align: justify;">US wavelength (length of a single sine-wave cycle in a medium) is related to fre- quency and speed of sound as follows:</p><p class="s31" style="padding-top: 3pt;padding-left: 185pt;text-indent: 0pt;text-align: justify;">c = f<span class="s32"></span></p><p style="padding-top: 5pt;padding-left: 21pt;text-indent: 0pt;line-height: 12pt;text-align: justify;">where c = speed of sound; f = frequency; and λ = wavelength.</p><p style="padding-left: 21pt;text-indent: 8pt;line-height: 94%;text-align: justify;">As an US beam passes through tissue, it loses energy and amplitude. The following contribute to the attenuation of the US beam:</p><p style="padding-top: 1pt;padding-left: 21pt;text-indent: 0pt;text-align: justify;"><span class="s23">◆ </span>Transfer of energy to tissue resulting in heating (<i>absorption</i>).</p><p class="s23" style="padding-top: 1pt;padding-left: 21pt;text-indent: 0pt;text-align: justify;">◆ <span class="p">Removal of energy by reflection and scattering.</span></p><p style="padding-top: 2pt;padding-left: 21pt;text-indent: 0pt;line-height: 94%;text-align: justify;">The <i>attenuation</i>—measured in decibels per centimetre (dB/cm)—is proportional to path length and frequency. Longer path lengths and higher frequencies produce greater attenuation. Thus the depth of the field available when imaging at higher fre- quency is shorter than at a lower frequency: higher frequencies (&gt;10 MHz) are used to image objects near to the skin surface, while lower frequencies (3–5 MHz) are used for tissue deeper within the body.</p><p style="padding-left: 21pt;text-indent: 8pt;line-height: 94%;text-align: justify;">Echoes are produced from boundaries between tissues with different mechanical properties. The amount reflected from an interface between two tissues depends on the difference in <i>acoustic impedance </i>(Table 2.5), a measure of the tissue’s resistance to distortion by US, in turn determined by the density and elasticity of the tissue. The in- tensity of the echo is proportional to the difference in acoustic impedance between the two tissues. For example, strong echoes are generated at a muscle:fat interface (inten- sity reflection coefficient = 1.5%). In most soft tissues, acoustic impedances are fairly similar, so the proportion of a sound pulse reflected at each interface is relatively small and most of the US energy is transmitted further into the body. If an US pulse encoun- ters reflectors that have dimensions smaller than its wavelength (i.e. d &lt; λ), then <i>scat- tering </i>occurs, with echoes reflected through a wide range of angles. For example, the <i>speckled </i>texture of organs like the liver is the result of interference between multiple</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s24" style="padding-top: 5pt;padding-left: 76pt;text-indent: 0pt;text-align: left;">Table 2.5 <span class="s25">acoustic impedance values of various tissues</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 76pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="265" height="1" alt="image" src="Image_008.png"/></span></p><p class="s39" style="padding-bottom: 2pt;padding-left: 76pt;text-indent: 0pt;text-align: left;">Tissue      Acoustic impedance (kg/m<span class="s40">(2)</span>/s)</p><p style="padding-left: 76pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="265" height="1" alt="image" src="Image_009.png"/></span></p><p class="s41" style="padding-top: 2pt;padding-bottom: 2pt;padding-left: 76pt;text-indent: 0pt;text-align: left;">air         0.0004 × 10<span class="s42">(6)</span></p><p style="padding-left: 76pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="269" height="1" alt="image" src="Image_010.png"/></span></p><p class="s41" style="padding-top: 2pt;padding-bottom: 2pt;padding-left: 76pt;text-indent: 0pt;text-align: left;">fat         1.38 × 10<span class="s42">(6)</span></p><p style="padding-left: 76pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="269" height="1" alt="image" src="Image_011.png"/></span></p><p class="s41" style="padding-top: 2pt;padding-bottom: 2pt;padding-left: 76pt;text-indent: 0pt;text-align: left;">Water       1.48 × 10<span class="s42">(6)</span></p><p style="padding-left: 76pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="269" height="1" alt="image" src="Image_012.png"/></span></p><p class="s41" style="padding-top: 2pt;padding-bottom: 2pt;padding-left: 76pt;text-indent: 0pt;text-align: left;">liver        1.65 × 10<span class="s42">(6)</span></p><p style="padding-left: 76pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="269" height="1" alt="image" src="Image_013.png"/></span></p><p class="s41" style="padding-top: 2pt;padding-bottom: 2pt;padding-left: 76pt;text-indent: 0pt;text-align: left;">Bone        7.80 × 10<span class="s42">(6)</span></p><p style="padding-left: 76pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="269" height="1" alt="image" src="Image_014.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 15pt;text-indent: 0pt;line-height: 94%;text-align: justify;">scattered echoes. The depth of any structure giving rise to an echo can be determined from the time taken for the sound pulse to reach it and the time for the echo to return to the surface, because the velocity of sound is very similar in all soft tissue. Echoes returning from greater depths must be amplified to compensate for the attenuation.</p><p class="s28" style="padding-top: 10pt;padding-left: 15pt;text-indent: 0pt;text-align: justify;">2.4.2 <span class="s29">Image generation</span></p><p style="padding-top: 3pt;padding-left: 15pt;text-indent: 0pt;line-height: 94%;text-align: justify;">US pulses required for image generation are produced by transducers consisting of piezoelectric elements which also receive the reflected US pulse producing real-time images. Transducers may be linear, curvilinear, or radial. Most modern US machines use transducers consisting of multiple arrays with as many as 196 elements. The US beam is not uniform, altering in configuration as it moves away from the transducer. Initially the beam converges after leaving the transducer. This corresponds to the near field and is narrowest at its focal distance; it then diverges. The US beam diameter is affected by:</p><p class="s23" style="padding-top: 2pt;padding-left: 27pt;text-indent: -11pt;line-height: 94%;text-align: justify;">◆ <span class="s12">US frequency</span><span class="p">: higher frequency US provides better image resolution as the near field is longer than at lower frequencies, but it is more heavily absorbed.</span></p><p class="s23" style="padding-top: 1pt;padding-left: 15pt;text-indent: 0pt;text-align: justify;">◆ <span class="s12">Distance from the transducer</span><span class="p">.</span></p><p class="s23" style="padding-top: 2pt;padding-left: 27pt;text-indent: -11pt;line-height: 94%;text-align: justify;">◆ <span class="s12">Transducer diameter</span><span class="p">: the near field is longer with larger diameter transducers, thus image resolution is better.</span></p><p class="s23" style="padding-top: 2pt;padding-left: 27pt;text-indent: -11pt;line-height: 94%;text-align: justify;">◆ <span class="s12">Use of mechanical or electronic </span><span class="p">focusing: focusing can only be achieved within the near field.</span></p><p style="padding-top: 2pt;padding-left: 15pt;text-indent: 0pt;line-height: 94%;text-align: justify;">Amplification of received echoes is necessary for image generation. Immediately after echoes are received by the transducer, echoes are pre-amplified uniformly. Noise and clutter are reduced by removal of small signals and demodulation.</p><p class="s28" style="padding-top: 10pt;padding-left: 15pt;text-indent: 0pt;text-align: left;">2.4.3 <span class="s29">Ultrasound methods</span></p><p style="padding-top: 3pt;padding-left: 15pt;text-indent: 0pt;line-height: 94%;text-align: justify;">Modern US scanners are based on B-mode imaging where echoes of differing magni- tudes are displayed as a greyscale. However, different methods can be applied to fur- ther improve imaging or obtain functional information.</p><p style="padding-left: 15pt;text-indent: 8pt;line-height: 94%;text-align: justify;">Tissue harmonic imaging is based on frequencies that are multiples of the frequency of the transmitted pulse (fundamental frequency). The second harmonic (twice the fundamental frequency) is most commonly used to generate an image. Artefacts and</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 5pt;padding-left: 21pt;text-indent: 0pt;line-height: 94%;text-align: justify;">clutter from multiple pulse reflections in surface tissues are also rejected, thus tissue harmonic imaging is ideal for patients with thick body walls who would normally be challenging and sub-optimally imaged.</p><p style="padding-left: 21pt;text-indent: 8pt;line-height: 94%;text-align: justify;">Spatial compound imaging is a method to reduce speckle. Electronic steering of the US beam is used to image the same tissue multiple times using parallel beams oriented along different directions. Echoes from these multiple acquisitions are then averaged into a single composite image with the effect of reducing speckle and improving con- trast and margin definition.</p><p style="padding-left: 21pt;text-indent: 8pt;line-height: 94%;text-align: justify;">Extended field of view imaging allows a single composite image with a large field of view to be obtained. By slowly translating the transducer laterally across the region of interest, multiple images are acquired which are registered relative to each other to generate a single composite image. This is useful to assess vessels, for example for deep venous thrombosis or stenotic disease.</p><p class="s28" style="padding-top: 10pt;padding-left: 21pt;text-indent: 0pt;text-align: left;">2.4.4 <span class="s29">Doppler ultrasound</span></p><p style="padding-top: 3pt;padding-left: 21pt;text-indent: 0pt;line-height: 94%;text-align: justify;">The Doppler principle states that there is a shift in frequency of a sound wave as the source of the sound moves relative to an observer. This change in frequency is called the Doppler frequency shift (DFS) which can be depicted by:</p><p class="s31" style="padding-top: 7pt;padding-left: 33pt;text-indent: 0pt;text-align: center;">DFS = (2 <span class="s32"></span><span class="s33"> </span>IF <span class="s32"></span><span class="s33"> </span>BF/c) <span class="s32"></span><span class="s33"> </span>cosine <span class="s32"></span></p><p style="padding-top: 6pt;padding-left: 21pt;text-indent: 0pt;line-height: 94%;text-align: justify;">where BF = blood flow; IF = incident frequency; c = speed of sound; θ = angle between the US beam and vascular flow.</p><p style="padding-left: 21pt;text-indent: 8pt;line-height: 94%;text-align: justify;">This can be exploited to demonstrate tissue or organ vascularity. Doppler techniques include:</p><p class="s23" style="padding-top: 2pt;padding-left: 33pt;text-indent: -11pt;line-height: 94%;text-align: justify;">◆ <span class="s12">Continuous wave (CW) Doppler</span><span class="p">: velocity is portrayed as a function of time. The blood flow patterns in the arteries can be shown by a simple CW Doppler device with two transducers, one for transmitting and one for receiving.</span></p><p class="s23" style="padding-top: 2pt;padding-left: 33pt;text-indent: -11pt;line-height: 94%;text-align: justify;">◆ <span class="s12">Pulsed Doppler</span><span class="p">: the spatial distribution of blood flow can be obtained from Doppler analysis of US pulses. Different velocities are portrayed in a range of colour in a 2D image. By convention, red represents flow towards and blue away from the transducer. Different intensities of colour represent velocity and turbulence.</span></p><p class="s23" style="padding-top: 2pt;padding-left: 33pt;text-indent: -11pt;line-height: 94%;text-align: justify;">◆ <span class="s12">Colour Doppler</span><span class="p">: B-mode images with superimposed Doppler information in colour.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s28" style="padding-left: 21pt;text-indent: 0pt;text-align: left;">2.4.5 <span class="s29">Imaging with ultrasound contrast agents</span></p><p style="padding-top: 3pt;padding-left: 21pt;text-indent: 0pt;line-height: 94%;text-align: justify;">These consist of gas microbubbles, stabilized by a shell of albumin or lipid, that have very different acoustic impedances from soft tissue. As the US contrast agent is in- jected into a vein and passes through the tissues being imaged the microbubbles are broken up by the US waves. The large number of small bubbles increases scatter, pro- ducing more echoes, enabling areas that are well perfused to be identified. For example, microbubbles enable differentiation of a benign liver lesion such as haemangioma or focal nodular hyperplasia from a metastasis (Figure 2.3).</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="text-indent: 0pt;text-align: left;"><span><img width="352" height="195" alt="image" src="Image_015.gif"/></span></p><p class="s30" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(a)</p><p class="s30" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(a)</p><p style="text-indent: 0pt;text-align: left;"/><p class="s30" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(a)</p><p class="s30" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(b)</p><p class="s30" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(b)</p><p style="text-indent: 0pt;text-align: left;"/><p class="s30" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(b)</p><p class="s24" style="padding-top: 3pt;padding-left: 15pt;text-indent: 0pt;line-height: 117%;text-align: left;">Fig. 2.3 <span class="s25">Contrast-enhanced uS images, with corresponding contrast-enhanced Ct showing a benign focal nodular hyperplasia.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s19" style="padding-top: 5pt;padding-left: 15pt;text-indent: 0pt;text-align: left;">2.5 <span class="h4">Magnetic resonance imaging</span></p><p style="padding-top: 4pt;padding-left: 15pt;text-indent: 0pt;line-height: 94%;text-align: justify;">MRI is a versatile technique, capable of multiplanar high-definition imaging of soft tissues with a good sensitivity and specificity. Whilst it does not carry the same risks of ionizing radiation exposure, special precautions to remove all ferromagnetic materials from the patient and to assess prosthetic implants for imaging suitability on online databases is required, for example cardiac pacemakers. It is also important to relate risk to magnetic field strength since an implant safe at one field strength may not be safe at another.</p><p class="s28" style="padding-top: 10pt;padding-left: 15pt;text-indent: 0pt;text-align: left;">2.5.1 <span class="s29">Magnetic resonance principles</span></p><p style="padding-top: 3pt;padding-left: 15pt;text-indent: 0pt;line-height: 94%;text-align: justify;">Three main types of magnet are used in clinical MRI installations: permanent ferromagnets, and resistive and superconducting electromagnets. The most com- monly used superconducting MRI scanners work at a field strength of 1.5 tesla. Lower field strengths may be preferred for specialist applications such as extremity imaging and higher field strengths confer advantages in image signal-to-noise, speed of acqui- sition or resolution.</p><p style="padding-left: 15pt;text-indent: 8pt;line-height: 89%;text-align: justify;">MR imaging is based on the principle that positively-charged protons in the body water line up with or against the magnetic field B<span class="s36">o</span>, depending on their energy. A rela- tively small number of them line up predominantly with the field, and are termed the net magnetization, <b>M</b><span class="s43">o</span><span class="s44">. For most applications, this is taken to lie along the main (Z) axis of the scanner, and therefore along the patient. The individual protons do not actually line up: they rotate or spin around the Z axis with a frequency directly proportional to the field strength: this is termed the </span><i>Larmor frequency </i>and is given by the <i>Larmor equation</i>:</p><p class="s32" style="padding-top: 8pt;padding-left: 45pt;text-indent: 0pt;text-align: center;"><span class="s45">o </span><span class="s46">= </span><span class="s47">B</span><span class="s48">o</span></p><p style="padding-top: 7pt;padding-left: 15pt;text-indent: 0pt;line-height: 82%;text-align: justify;">where ω<span class="s36">o </span>is the angular frequency of rotation, γ is the gyromagnetic ratio (constant of proportionality: fixed for a given nucleus) and <span class="s49">B</span><span class="s43">o </span><span class="s44">the magnetic field strength in tesla</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 5pt;padding-left: 21pt;text-indent: 0pt;line-height: 94%;text-align: justify;">(T). Bold italic text indicates a vector quantity, that is, there is implied direction as well as magnitude. The nuclei are usually referred to as <i>spins</i>.</p><p style="padding-left: 21pt;text-indent: 8pt;line-height: 94%;text-align: justify;">To acquire an image, a radiofrequency (RF) energy pulse with a bandwidth of fre- quencies centred around the Larmor frequency is produced using an RF power amp- lifier. It feeds currents to the RF transmit coil (usually the <i>body coil</i>), producing a circularly polarized magnetic field. This so-called <span class="s49">B</span><span class="s50">1</span> field locally overcomes the main field <span class="s49">B</span><span class="s43">o </span><span class="s44">and so the net magnetisation tips to rotate around the </span><span class="s49">B</span><span class="s50">1</span> field direction in-</p><p style="padding-left: 21pt;text-indent: 0pt;line-height: 10pt;text-align: justify;">stead, gaining energy as they do so. The RF pulses can either be given enough energy to</p><p style="padding-left: 21pt;text-indent: 0pt;line-height: 94%;text-align: justify;">flip the spins exactly orthogonal to their starting position (the RF pulse is then termed a 90<span class="s22">° </span>pulse), antiparallel to it (180<span class="s22">° </span>pulse), or any intermediate angle.</p><p style="padding-left: 21pt;text-indent: 8pt;line-height: 94%;text-align: justify;">At the end of the RF pulse, the orientation of the spins returns to its base position giving off the energy they gained in an exponential decay, characterized by <i>relaxation times</i>, termed T1 and T2. The energy release is detected either by the same coil used to transmit the RF pulse, or a smaller, more sensitive <i>surface coil </i>which is much closer to the tissue of interest and can acquire higher resolution data. Most data are acquired via surface coils.</p><p class="s28" style="padding-top: 10pt;padding-left: 21pt;text-indent: 0pt;text-align: justify;">2.5.2 <span class="s29">Image generation</span></p><p style="padding-top: 3pt;padding-left: 21pt;text-indent: 0pt;line-height: 94%;text-align: justify;">A ‘slice’ of the patient is selected by applying a gradient, which changes the Larmor frequencies of spins along itself. This can be in any orientation, as the XYZ gradients can be used singly or in combination. An RF pulse with a given bandwidth of fre- quencies is applied, and only those spins in the patient with corresponding Larmor frequencies will be excited. The spins in the slice are then encoded using an orthog- onal combination of gradients in Z (transverse, or axial), X (sagittal), and Y (coronal) orientations. For a typical axial image, X will be termed the ‘frequency encoding’ direction and Y the ‘phase encoding’ direction. However, this encoding takes time, and the <i>free induction decay </i>(FID, the exponential decay of the signal as the protons return to their original position), is usually much faster than the time it takes to perform the encoding. To compensate for this, more gradients and/or (usually) 180<span class="s22">° </span>RF pulses are used to form an <i>echo </i>of the initial signal, which is detected after the encoding. If the echo is formed by an RF pulse, it is termed a <i>spin echo</i>; if a gradient is used, it is a <i>gradient echo</i>. A diagram of spin echo formation (and associated T2<span class="s22">* </span>decay) is given in Figure 2.4.</p><p style="padding-left: 29pt;text-indent: 0pt;line-height: 11pt;text-align: justify;">Images are built up line by line using multiple <i>repetitions </i>of pulse + gradient</p><p style="padding-left: 21pt;text-indent: 0pt;line-height: 94%;text-align: justify;">sequences and the signal amplitudes of each line recorded by the computers in the scanner. At the end of a sequence, the images are reconstructed using a mathematical transformation called a <i>Fourier transform</i>. Usually, sequences can be designed to col- lect many image slices at once, in order to save time.</p><p style="padding-left: 21pt;text-indent: 8pt;line-height: 94%;text-align: justify;">Variables which can be changed by the scanner operator include the echo time TE, repetition time TR, and flip angle, α. These cause the amount of relaxation in the spins to vary before signal readout, and a knowledge of the intrinsic relaxation times T1 and T2 for a given tissue allows the changing of image contrast between imaging sequences, allowing different physiological characteristics to be assessed. Most basic images are therefore termed T1<i>-weighted </i>or T2<i>-weighted </i>(Figure 2.5).</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s128" style="padding-left: 57pt;text-indent: 0pt;text-align: left;">		</p><p style="text-indent: 0pt;text-align: left;"><span><img width="182" height="166" alt="image" src="Image_016.png"/></span></p><p class="s51" style="text-indent: 0pt;text-align: left;">Z’</p><p class="s51" style="text-indent: 0pt;text-align: left;">Z’</p><p style="text-indent: 0pt;text-align: left;"/><p class="s51" style="text-indent: 0pt;text-align: left;">Z’</p><p class="s52" style="text-indent: 0pt;text-align: left;">M<span class="s53">0</span></p><p class="s52" style="text-indent: 0pt;text-align: left;">M<span class="s53">0</span></p><p style="text-indent: 0pt;text-align: left;"/><p class="s52" style="text-indent: 0pt;text-align: left;">M<span class="s53">0</span></p><p class="s51" style="text-indent: 0pt;text-align: left;">Y’</p><p class="s51" style="text-indent: 0pt;text-align: left;">Y’</p><p style="text-indent: 0pt;text-align: left;"/><p class="s51" style="text-indent: 0pt;text-align: left;">Y’</p><p class="s51" style="text-indent: 0pt;text-align: left;">X’</p><p class="s51" style="text-indent: 0pt;text-align: left;">X’</p><p style="text-indent: 0pt;text-align: left;"/><p class="s51" style="text-indent: 0pt;text-align: left;">X’</p><p class="s54" style="padding-left: 35pt;text-indent: 0pt;text-align: left;">a) <span class="s55">Initial state of net magnetization M</span><span class="s56">0   </span><span class="s57">b)</span></p><p class="s52" style="padding-left: 20pt;text-indent: -17pt;text-align: left;">Magnetization after a 90<span class="s58">° </span>pulse</p><p class="s59" style="padding-left: 48pt;text-indent: -13pt;line-height: 10pt;text-align: left;">c) <span class="s55">T2* relaxation takes place after the 90</span><span class="s58">° </span><span class="s52">pulse, the spins fan out in the</span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="182" height="166" alt="image" src="Image_017.png"/></span></p><p class="s51" style="text-indent: 0pt;text-align: left;">Z’</p><p class="s51" style="text-indent: 0pt;text-align: left;">Z’</p><p style="text-indent: 0pt;text-align: left;"/><p class="s51" style="text-indent: 0pt;text-align: left;">Z’</p><p class="s51" style="text-indent: 0pt;text-align: left;">Y’</p><p class="s51" style="text-indent: 0pt;text-align: left;">Y’</p><p style="text-indent: 0pt;text-align: left;"/><p class="s51" style="text-indent: 0pt;text-align: left;">Y’</p><p class="s51" style="text-indent: 0pt;text-align: left;">X’</p><p class="s51" style="text-indent: 0pt;text-align: left;">X’</p><p style="text-indent: 0pt;text-align: left;"/><p class="s51" style="text-indent: 0pt;text-align: left;">X’</p><p style="text-indent: 0pt;text-align: left;"><span><img width="182" height="166" alt="image" src="Image_018.png"/></span></p><p class="s51" style="text-indent: 0pt;text-align: left;">Z’</p><p class="s51" style="text-indent: 0pt;text-align: left;">Z’</p><p style="text-indent: 0pt;text-align: left;"/><p class="s51" style="text-indent: 0pt;text-align: left;">Z’</p><p class="s51" style="text-indent: 0pt;text-align: left;">Y’</p><p class="s51" style="text-indent: 0pt;text-align: left;">Y’</p><p style="text-indent: 0pt;text-align: left;"/><p class="s51" style="text-indent: 0pt;text-align: left;">Y’</p><p class="s52" style="text-indent: 0pt;text-align: left;">M<span class="s53">x</span></p><p class="s52" style="text-indent: 0pt;text-align: left;">M<span class="s53">x</span></p><p style="text-indent: 0pt;text-align: left;"/><p class="s52" style="text-indent: 0pt;text-align: left;">M<span class="s53">x</span></p><p class="s51" style="text-indent: 0pt;text-align: left;">X’</p><p class="s51" style="text-indent: 0pt;text-align: left;">X’</p><p style="text-indent: 0pt;text-align: left;"/><p class="s51" style="text-indent: 0pt;text-align: left;">X’</p><p style="text-indent: 0pt;text-align: left;"><span><img width="182" height="166" alt="image" src="Image_019.png"/></span></p><p class="s51" style="text-indent: 0pt;text-align: left;">Z’</p><p class="s51" style="text-indent: 0pt;text-align: left;">Z’</p><p style="text-indent: 0pt;text-align: left;"/><p class="s51" style="text-indent: 0pt;text-align: left;">Z’</p><p class="s51" style="text-indent: 0pt;text-align: left;">Y’</p><p class="s51" style="text-indent: 0pt;text-align: left;">Y’</p><p style="text-indent: 0pt;text-align: left;"/><p class="s51" style="text-indent: 0pt;text-align: left;">Y’</p><p class="s51" style="text-indent: 0pt;text-align: left;">X’</p><p class="s51" style="text-indent: 0pt;text-align: left;">X’</p><p style="text-indent: 0pt;text-align: left;"/><p class="s51" style="text-indent: 0pt;text-align: left;">X’</p><p style="text-indent: 0pt;text-align: left;"><span><img width="182" height="166" alt="image" src="Image_020.png"/></span></p><p class="s51" style="text-indent: 0pt;text-align: left;">Z’</p><p class="s51" style="text-indent: 0pt;text-align: left;">Z’</p><p style="text-indent: 0pt;text-align: left;"/><p class="s51" style="text-indent: 0pt;text-align: left;">Z’</p><p class="s51" style="text-indent: 0pt;text-align: left;">Y’</p><p class="s51" style="text-indent: 0pt;text-align: left;">Y’</p><p style="text-indent: 0pt;text-align: left;"/><p class="s51" style="text-indent: 0pt;text-align: left;">Y’</p><p class="s51" style="text-indent: 0pt;text-align: left;">X’</p><p class="s51" style="text-indent: 0pt;text-align: left;">X’</p><p style="text-indent: 0pt;text-align: left;"/><p class="s51" style="text-indent: 0pt;text-align: left;">X’</p><p style="text-indent: 0pt;text-align: left;"><span><img width="182" height="166" alt="image" src="Image_021.png"/></span></p><p class="s51" style="text-indent: 0pt;text-align: left;">Z’</p><p class="s51" style="text-indent: 0pt;text-align: left;">Z’</p><p style="text-indent: 0pt;text-align: left;"/><p class="s51" style="text-indent: 0pt;text-align: left;">Z’</p><p class="s51" style="text-indent: 0pt;text-align: left;">Y’</p><p class="s51" style="text-indent: 0pt;text-align: left;">Y’</p><p style="text-indent: 0pt;text-align: left;"/><p class="s51" style="text-indent: 0pt;text-align: left;">Y’</p><p class="s51" style="text-indent: 0pt;text-align: left;">X’</p><p class="s51" style="text-indent: 0pt;text-align: left;">X’</p><p style="text-indent: 0pt;text-align: left;"/><p class="s51" style="text-indent: 0pt;text-align: left;">X’</p><p class="s60" style="text-indent: 0pt;line-height: 12pt;text-align: left;">M<span class="s61">XY</span></p><p class="s60" style="text-indent: 0pt;line-height: 12pt;text-align: left;">M<span class="s61">XY</span></p><p style="text-indent: 0pt;text-align: left;"/><p class="s60" style="text-indent: 0pt;line-height: 12pt;text-align: left;">M<span class="s61">XY</span></p><p class="s52" style="padding-left: 42pt;text-indent: 0pt;text-align: left;">X ‘Y’ plane due to B<span class="s53">0 </span>inhomogeneity</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s128" style="padding-left: 58pt;text-indent: 0pt;text-align: left;">		</p><p class="s54" style="padding-top: 5pt;padding-left: 65pt;text-indent: 1pt;text-align: left;">d) <span class="s55">Spins at the end of the free induction decay</span></p><p class="s24" style="padding-top: 4pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Fig. 2.4 <span class="s25">diagram showing spin echo formation.</span></p><p class="s54" style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">e) <span class="s55">Effects of a 180</span><span class="s58">° </span><span class="s52">pulse</span></p><p class="s59" style="padding-top: 4pt;padding-left: 26pt;text-indent: -21pt;text-align: left;">f) <span class="s55">The spins rephase to give an echo</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="text-indent: 0pt;text-align: left;"><span><img width="431" height="287" alt="image" src="Image_022.gif"/></span></p><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(a)</p><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(a)</p><p style="text-indent: 0pt;text-align: left;"/><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(a)</p><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(b)</p><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(b)</p><p style="text-indent: 0pt;text-align: left;"/><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(b)</p><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(c)</p><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(c)</p><p style="text-indent: 0pt;text-align: left;"/><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(c)</p><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(d)</p><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(d)</p><p style="text-indent: 0pt;text-align: left;"/><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(d)</p><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(e)</p><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(e)</p><p style="text-indent: 0pt;text-align: left;"/><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(e)</p><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(f)</p><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(f)</p><p style="text-indent: 0pt;text-align: left;"/><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(f)</p><p class="s24" style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;line-height: 117%;text-align: left;">Fig. 2.5 <span class="s25">mr images acquired at 1.5 t showing colorectal liver metastases: t1-weighted pre-contrast (a), t2-weighted (b), Pd-weighted (c), t1-weighted postcontrast (d),</span></p><p class="s25" style="padding-left: 11pt;text-indent: 0pt;line-height: 10pt;text-align: left;">t1 subtraction (e), and adC map (f).</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 5pt;padding-left: 11pt;text-indent: 8pt;line-height: 94%;text-align: justify;">T1-weighted scans have short TE and short TR, and show long T1 tissues as dark and short T1 tissues as bright. Contrast agents such as gadolinium, which tend to shorten T1, therefore highlight tissues where it is taken up. Water, which has a long T1, appears relatively dark, and fat, with a short T1 is bright. T2-weighted scans have long TE and long TR. They show tissues with longer T2 as bright, as the shorter T2 tissues’ signal will have decayed away at the long echo times used. This is very useful for showing fluid around tumours, for example gliomas, or tumours in prostate per- ipheral zones, where the tumour appears darker than the peripheral zone. Fat is less bright than water. Another common sequence used is termed <i>proton-density </i>(Figure 2.5) as it shows the relative proton densities within the slice. Gradient echo sequences bring in another relaxation time weighting called T2<i>*</i>, which allows magnetic field variations to be assessed.</p><p style="padding-left: 11pt;text-indent: 8pt;line-height: 94%;text-align: justify;">In Figure 2.4, T2* is the decay constant of the FID. This can be refocused by a spin echo but not a gradient echo sequence, thus is only a significant contrast mechanism in the latter. A combination of T2* and T1-weighting is useful for looking at con- trast agents such as ferromagnetic or gadolinium particles, which work by changing the local field around them, and therefore the tissue relaxation times. A post-contrast T1-weighted gradient echo image is shown in comparison with the pre-contrast (Figure 2.5).</p><p class="s28" style="padding-top: 4pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">2.5.3 <span class="s29">Advanced imaging</span></p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 94%;text-align: justify;">Modern scanners permit more flexible scanning beyond basic spin and gradient echo sequences. This stems from technological developments including <i>parallel imaging </i>speeding up acquisition, increasing resolution, and reducing scan time. Another de- velopment is implementation of echo-planar imaging (EPI). This technique requires very fast gradient switching, but can acquire an entire image in &lt;1 s. It enables meas- urement of physiological factors such as <i>water diffusion </i>in tissues: depending on the cellular organization and density, this can be predominantly in one direction (iso- tropic) or all (anisotropic), restricted (dense cellular structure) or unrestricted (loose structure) (Figure 2.5).</p><p style="padding-left: 5pt;text-indent: 8pt;line-height: 94%;text-align: justify;">Dynamic contrast-enhanced (DCE) MRI (Figure 2.6) consists of injecting contrast, usually gadolinium-based, while rapid T1-weighted gradient echo or EPI scanning takes place. Permeability of the vasculature can be assessed both semi-quantitatively evaluating the initial area under the gadolinium concentration-time curve in the first minute (IAUGC<span class="s36">60</span>) or by generating fully-quantitative data such as K<span class="s22">trans </span>(the rate at</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 10pt;text-align: justify;">which the contrast passes into the extracellular space), the extracellular space volume,</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 82%;text-align: justify;">v<span class="s36">e</span>, the onset time at which the contrast arrives at a given region, and the rate at which it passes back out to the plasma again, k<span class="s36">ep</span>.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="text-indent: 0pt;text-align: left;"><span><img width="431" height="308" alt="image" src="Image_023.jpg"/></span></p><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(a)</p><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(a)</p><p style="text-indent: 0pt;text-align: left;"/><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(a)</p><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(b)</p><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(b)</p><p style="text-indent: 0pt;text-align: left;"/><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(b)</p><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(c)</p><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(c)</p><p style="text-indent: 0pt;text-align: left;"/><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(c)</p><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(d)</p><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(d)</p><p style="text-indent: 0pt;text-align: left;"/><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(d)</p><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(e)</p><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(e)</p><p style="text-indent: 0pt;text-align: left;"/><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(e)</p><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(f)</p><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(f)</p><p style="text-indent: 0pt;text-align: left;"/><p class="s62" style="text-indent: 0pt;line-height: 9pt;text-align: left;">(f)</p><p class="s25" style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 117%;text-align: left;"><span class="s24">Fig. 2.6 </span>Parametric images, all calculated from one dCe-mrI data set of 40 images: (a) K<span class="s63">trans</span>; (b) v<span class="s64">e</span>; (c) onset time; (d) k<span class="s64">ep</span>; (e) IauGC<span class="s64">60; and </span>(f) hepatic perfusion index.</p><p class="s19" style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">2.6 <span class="h4">Radionuclide radiology</span></p><p style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;line-height: 94%;text-align: justify;">This section deals with common investigative techniques that utilize the adminis- tration of a radiopharmaceutical, which is then imaged (or counted) with a gamma camera, concentrating on the management of patients with malignant conditions.</p><p class="s28" style="padding-top: 10pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">2.6.1 <span class="s29">The radiopharmaceutical (radiotracer)</span></p><p style="padding-top: 3pt;padding-left: 11pt;text-indent: 0pt;line-height: 94%;text-align: justify;">A radiopharmaceutical consists of a radionuclide bound to a pharmaceutical. The radionuclide provides the gamma radiation which forms the image and is chosen for its physical properties of half-life, gamma energy emitted (i.e. in the range of 100–250 keV which is best captured by a gamma camera), ‘purity’ of emission (i.e. no undesir- able alpha or beta particles), and simplicity of production. It should also bind well to the bioactive compound or molecule, not dissociating under physiological conditions. The pharmaceutical enables the targeting of the particular physiological process of interest to the investigator. This can range from osteoblastic activity to left ventricular ejection fraction to specific peptide receptor expression.</p><p style="padding-left: 11pt;text-indent: 8pt;line-height: 94%;text-align: justify;">Some physiological processes can be targeted by the radionuclide without a pharma- ceutical. Iodine transport in the thyroid via the sodium iodine symporter can be im- aged with radioisotopes of iodine, <span class="s22">123</span>I and <span class="s22">131</span>I. For imaging <span class="s22">123</span>I is preferred as it is a pure gamma emitter, whereas <span class="s22">131</span>I is also a beta emitter and therefore can be used for therapy. <span class="s22">123</span>I can only be produced in a cyclotron, limiting its availability and so benign thyroid disease is imaged with <span class="s22">99m</span>Tc-pertechnetate which follows a similar physio- logical pathway.</p><p class="s65" style="padding-left: 11pt;text-indent: 8pt;line-height: 94%;text-align: justify;">99m<span class="s44">Tc (an isomer of technetium) is the workhorse of the nuclear medicine depart- ment due to its ideal imaging properties. It emits a 140 keV gamma ray, giving good penetration of soft tissue, while causing minimal damage. This energy is ideal for imaging by the gamma camera crystal. Its half-life of 6.03 hours is convenient for the logistics of production, administration, and imaging over a few hours—and short enough to allow acceptable outpatient use (it does not linger, giving the patient and surroundings ongoing radiation exposure). The daughter isotope </span>99<span class="s44">Tc (a beta emitter) has a long half-life and is excreted in the urine before it decays. It is generated from molybdenum-99 which has a long half-life of 66 hours, allowing a generator to last a working week. It readily binds to a variety of pharmaceuticals.</span></p><p class="s28" style="padding-top: 9pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">2.6.2 <span class="s29">The gamma camera</span></p><p style="padding-top: 3pt;padding-left: 11pt;text-indent: 0pt;line-height: 94%;text-align: justify;">A gamma camera consists of crystals linked to photomultiplier tubes (PMTs). The crystals consisting of sodium iodide with added thallium capture the incident gamma photons emitted from the patient. The photon releases its energy to an electron, exciting it. The electron then falls back to a lower energy state and a light photon is emitted. The crystal is linked to a close fitting array of PMTs which amplify and locate the signal. The incident light photons from the crystal hit the entry window which is a photocathode. They liberate electrons—the photoelectric effect. These are accelerated and amplified via a series of dynodes through the tube to reach the end anode. This produces a current which gives a voltage which varies over time depending on the en- ergy of the original gamma photon. Every incident gamma photon on the crystal will</p><p style="padding-top: 4pt;padding-left: 5pt;text-indent: 0pt;line-height: 94%;text-align: justify;">produce a scatter of light from the crystal into a group of PMTs at varying distances from the collision. The relative intensity of the signal from each neighbouring tube can be compared to give the location of each collision event.</p><p style="padding-left: 5pt;text-indent: 8pt;line-height: 94%;text-align: justify;">As gamma photons leave the patient in random directions, a collimator is placed between the patient and crystal to exclude radiation that is not useful in forming the image, thus bringing the image into ‘focus’. The collimator excludes radiation with an oblique incident angle (by absorption and scatter)—only allowing through gamma photons at a narrow angle useful in forming the image. The choice of collimator de- pends on the gamma energies involved and the particular examination. The most commonly used is a lead collimator with a series of parallel holes. A pinhole collimator is a cone which works like a camera obscura, giving a sharp image but with a small field of view and longer imaging time.</p><p style="padding-left: 5pt;text-indent: 8pt;line-height: 94%;text-align: justify;">A computer system controls the operation of the camera, acquisition, and storage of acquired images. It is important for image quality to have the head as close as possible to the patient. A simple gamma camera has a single head and is static. A dual-headed camera can image a patient from two different angles simultaneously. Either can be used with a moving table. The heads can be positioned manually or automatically. Some have software and infrared sensors to adjust the position of the head according to the contours of the patient’s body as it moves past. Pressure sensors stop the move- ment of the table if the gamma camera head is touched.</p><p class="s28" style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">2.6.3 <span class="s29">Single photon emission computed tomography</span></p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 94%;text-align: justify;">A single photon emission computed tomography (SPECT) camera is a type of gamma camera. It can acquire images tomographically. SPECT imaging is analogous to X-ray CT in that the image is acquired by rotating detectors around the patient, that is, gamma camera heads (usually two) then reconstructing an image in three planes. This local- izes the focus of activity in 3D and improves the visualization of faint foci of activity. Very intense concentrations of activity (e.g. the bladder in a bone scan) will produce artefacts, obscuring activity in adjacent structures. SPECT acquisitions can be gated to an electrocardiogram (ECG) allowing imaging of the myocardium and definition of the left ventricular volume. Gamma camera images can also be co-registered with radiographs and CT images to further localize the physiological process to the anatomy.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s28" style="padding-left: 5pt;text-indent: 0pt;text-align: left;">2.6.4 <span class="s29">Imaging</span></p><p style="padding-top: 4pt;padding-left: 5pt;text-indent: 0pt;line-height: 94%;text-align: justify;">Once the radiopharmaceutical is administered then, depending upon the half-life, multiple subsequent images can be obtained with no further patient dose (unlike X-rays). This allows images of different phases of the radiopharmaceutical’s pro- gress through the patient, for example the perfusion, blood pool, and delayed skel- etal images of a bone scan, or several views of the same body part from various projections.</p><p style="padding-left: 5pt;text-indent: 8pt;line-height: 94%;text-align: justify;">Data can be acquired in dynamic or ‘spot’ modes. The dynamic mode measures ac- tivity level as it changes over time. It is used for physiological processes which operate in the time period of the scan, for example the passage of tracer through the kidneys in a MAG3 (mercaptoacetyltriglycine) renogram. The data can be displayed as a series</p><p style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;line-height: 94%;text-align: justify;">of images or as a time-activity graph. The spot mode records the sum of all activity in a given time. It is used for activity which is more or less constant during the scan, for example renal cortical activity in a DMSA (dimercaptosuccinic acid) scan. The data can also be used to produce an image or as a number of total counts, giving the relative function in various defined regions of interest.</p><p style="padding-left: 11pt;text-indent: 8pt;line-height: 94%;text-align: justify;">Thus the image produced is not directly of an organ or patient, but a map of the amount of the physiological process under study within the organ or patient. Therefore, on a DMSA study, an image of a fully functioning kidney will be kidney shaped but a damaged kidney will produce an irregular image, indicating the level of function within different parts of the kidney. Gamma camera images can be co-registered with radiographs and CT images to further localize the physiological process to the anatomy. In cardiac imaging, acquisitions can be gated to an ECG, allowing imaging of the myocardium or left ventricular volume.</p><p style="padding-left: 11pt;text-indent: 8pt;line-height: 94%;text-align: justify;">The great strength of these techniques is that they complement the anatomical detail of radiological examinations with functional information. The target physiology can be highly specific, for example iodine uptake in a deposit of papillary thyroid carcinoma. Often, however, the physiological process targeted is a surrogate marker for malignancy. This can reduce the specificity, for example gallium uptake as a marker for metabolic activity and transferrin receptor status is increased in lymphoma, but also sarcoidosis.</p><p style="padding-left: 11pt;text-indent: 8pt;line-height: 94%;text-align: justify;">An isotope bone scan uses osteoblastic activity as a marker for the presence of me- tastases and so produces false negatives if there are lytic deposits with a poor osteo- blastic reaction and false positives due to osteoblastic reactions to other processes such as fractures or infection. This makes it essential to interpret results in conjunction with the complete clinical picture, particularly correlating functional and anatomical investigations.</p><p style="padding-left: 11pt;text-indent: 8pt;line-height: 94%;text-align: justify;">The following are examples of the way in which radionuclide imaging contributes to the management of patients with malignancy.</p><p class="s28" style="padding-top: 6pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">2.6.4.1 <span class="s66">The isotope bone scan</span></p><p style="padding-top: 2pt;padding-left: 11pt;text-indent: 0pt;line-height: 94%;text-align: justify;">The radiopharmaceutical <span class="s22">99m</span>Tc MDP (methylene-diphosphonate) is taken up by active osteoblasts. Osteoblastic activity may be a marker for the presence of metastases but will produce false positives due to osteoblastic reactions in other processes such as fractures or infection and false negatives with lytic deposits with a poor osteoblastic reaction. Causes of apparent increased activity on a <span class="s22">99m</span>Tc MDP bone scan include:</p><p class="s23" style="padding-top: 1pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">◆ <span class="p">True increased osteoblastic activity.</span></p><p class="s23" style="padding-top: 1pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">◆ <span class="p">Increased arterial supply to a body part, for example inflammation.</span></p><p class="s23" style="padding-top: 1pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">◆ <span class="p">Impaired venous drainage of a body part, for example deep vein thrombosis.</span></p><p class="s23" style="padding-top: 1pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">◆ <span class="p">Excretion of radiopharmaceutical, for example in urine.</span></p><p class="s23" style="padding-top: 2pt;padding-left: 23pt;text-indent: -11pt;line-height: 94%;text-align: left;">◆ <span class="p">Distance from gamma camera head, for example iliac crests appear more active on anterior images, sacroiliac joints appear more active on posterior images.</span></p><p class="s23" style="padding-top: 2pt;padding-left: 23pt;text-indent: -11pt;line-height: 94%;text-align: left;">◆ <span class="p">Lack of intervening soft tissue, for example the pectoral muscles attenuate gamma photons from the ribs but not the sternum.</span></p><p class="s23" style="padding-top: 2pt;padding-left: 23pt;text-indent: -11pt;line-height: 94%;text-align: left;">◆ <span class="p">Thickness of bone, for example the distal humerus has a greater volume of bone than the shaft, producing a difference in apparent activity.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 85pt;text-indent: 0pt;text-align: left;"><span><img width="219" height="248" alt="image" src="Image_024.gif"/></span></p><p class="s24" style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 117%;text-align: left;">Fig. 2.7 <span class="s25">99mtc mdP bone scan: patchy diffuse foci of increased activity throughout the central axial skeleton and proximal long bones with low background and renal activity indicates a metastatic ‘superscan’. this results from the osteoblastic response to the widespread skeletal malignant deposits typical of prostate carcinoma metastases.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;line-height: 94%;text-align: justify;">True osteoblastic activity can be in response to many processes, from malignancy to infection, Paget’s disease to fractures. Thus the art of interpretation is to pay attention to the pattern of activity and correlation with the clinical picture and other imaging techniques (Figure 2.7). Lytic deposits without osteoblastic reactions will produce photopenic ‘holes’ in the normal bone activity. The isotope bone scan can also dem- onstrate paraneoplastic processes such as hypertrophic osteoarthropathy (Figure 2.8).</p><p class="s28" style="padding-top: 7pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">2.6.4.2 <span class="s66">The multi-gated acquisition scan</span></p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 94%;text-align: justify;">Multi-gated acquisition (some companies use analysis) (MUGA) is a technique used as a method of measuring left ventricular ejection fraction in a reproducible manner. This is important in oncology for monitoring patients undergoing therapies with cardiotoxic side effects such as trastuzumab.</p><p style="padding-left: 5pt;text-indent: 8pt;line-height: 94%;text-align: justify;">To assess the left ventricular luminal volume the radiotracer must stay within the intravascular space, thus red blood cells are the ideal ‘tracer’. In order to label the red cells with the radionuclide (<span class="s22">99m</span>Tc), the patient is injected with a stannous (tin) salt. Later the pertechnetate is injected, enters the red cell, is reduced by the stannous salt, and then cannot diffuse back out again. A more laborious <i>in vitro </i>labelling method is described but not often used in clinical departments.</p><p style="padding-left: 5pt;text-indent: 8pt;line-height: 94%;text-align: justify;">The camera head is put in an oblique position to throw the left ventricle into relief, free of overlapping structures, and the number of radioactive counts obtained over about 10–15 min. This data acquisition is gated to an ECG, so the software can divide the counts into those acquired during different phases of the cardiac cycle, plotting a graph of activity versus phase of cardiac cycle. The total activity in all the time points</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 94pt;text-indent: 0pt;text-align: left;"><span><img width="208" height="337" alt="image" src="Image_025.gif"/></span></p><p class="s24" style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;line-height: 117%;text-align: left;">Fig. 2.8 <span class="s25">Irregular increased cortical activity in both femora in a patient with lung cancer, typical of Hoa.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 5pt;padding-left: 11pt;text-indent: 0pt;line-height: 94%;text-align: justify;">in end systole is compared to those in end diastole. This activity is proportional to the volume of the ventricle and so an ejection fraction can be calculated.</p><p style="padding-left: 11pt;text-indent: 8pt;line-height: 94%;text-align: justify;">The final report includes a summated image acquired in end systole and end diastole to demonstrate the regions of interest have been accurately sited over the left ventricle and area of lung for background correction and that there is no overlapping activity from adjacent structures, such as the spleen. There is also a diagram showing the wall motion divided into segments, but the oncologist will generally be interested in the overall percentage figure and any change in the value over the course of treatment.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s19" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">2.7 <span class="h4">Positron emission tomography</span></p><p style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;line-height: 94%;text-align: justify;">Positron emission tomography (PET) is used for detecting and localizing cancers, distinguishing benign from malignant tumours, staging, and monitoring response to treatment. It is generally more sensitive than anatomical imaging for cancer detection, and may be more specific.</p><p class="s28" style="padding-top: 10pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">2.7.1 <span class="s29">Basic principles</span></p><p style="padding-top: 3pt;padding-left: 11pt;text-indent: 0pt;line-height: 94%;text-align: justify;">PET relies upon the administration of positron-emitting radio pharmaceuticals, of which the most common in routine use is the glucose analogue <span class="s22">18</span>F-fluorodeoxyglucose (<span class="s22">18</span>F-FDG). The <span class="s22">18</span>F molecule is unstable and decays via emission of a positron and</p><p style="padding-top: 4pt;padding-left: 5pt;text-indent: 0pt;line-height: 94%;text-align: justify;">neutrino to form stable non-toxic <span class="s22">18</span>O. Energetic emitted positrons scatter with electrons in tissue before combining to annihilate, creating two 511 keV photons emitted ~180° apart that are detected in PET scanners.</p><p style="padding-left: 5pt;text-indent: 8pt;line-height: 94%;text-align: justify;">These two emitted 511 keV photons travel through tissue before being recorded in rings of detectors surrounding the patient. The detectors consist of scintillator crys- tals coupled to photo multiplier tubes where interacting photons create pulses of light that are converted to electrical signals. If two signals are recorded within a small time window (nanoseconds) in the detection circuitry then a coincidence event has poten- tially occurred, creating a line-of-response (LOR) that defines the relative position of the event for use in image reconstruction.</p><p style="padding-left: 5pt;text-indent: 8pt;line-height: 94%;text-align: justify;">Typical crystal scintillators employed today are based on bismuth germanate (BGO), lutetium oxyorthosilicate (LSO), and gadolinium oxyorthosilicate (GSO). Required characteristics for PET crystals are high detection efficiency for good sensitivity, fast speed to reduce random noise, and good energy resolution to reduce scatter. Some scanners can be operated in 2D or 3D acquisition mode. In 2D scanning, physical septa are placed between detector rings to accept relatively parallel LOR in order to reduce interplane scatter (~20%) and enable simple and speedy image reconstruction at the expense of detection sensitivity. In 3D scanning, septa are retracted and all LOR are accepted, resulting in approximately five times the sensitivity compared with 2D. However, scatter increases by up to 50%, as do random events, thus requiring superior timing and scatter compensation in hardware and software compared with 2D. In 3D more bed positions are also scanned due to the non-uniform axial sensitivity encoun- tered. Modern scanners utilize 3D-list mode data acquisition for increased versatility with iterative image reconstruction and recent fast time-of-flight systems offer su- perior signal-to-noise ratio.</p><p class="s28" style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">2.7.2 <span class="s29">Fundamental limitations</span></p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 94%;text-align: justify;">Positron range depends upon its kinetic energy and Table 2.6 illustrates this for dif- ferent radiopharmaceuticals and tissues. The residual kinetic energy of the positron before annihilation translates into an angular variation of ~0.5° for photons created post annihilation. FDG positron range and photon non-collinearity are limitations to image resolution.</p><p class="s24" style="padding-top: 8pt;padding-left: 9pt;text-indent: 0pt;text-align: justify;">Table 2.6 <span class="s25">the effect of energy on positron range in different tissues</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><table style="border-collapse:collapse;margin-left:9.4253pt" cellspacing="0"><tr style="height:12pt"><td style="width:56pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9"><p class="s26" style="padding-top: 1pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Radioisotope</p></td><td style="width:62pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9"><p class="s26" style="padding-top: 1pt;padding-left: 8pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Max energy</p></td><td style="width:69pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9"><p class="s26" style="padding-top: 1pt;padding-left: 11pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Cortical bone</p></td><td style="width:63pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9"><p class="s26" style="padding-top: 1pt;padding-left: 9pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Soft tissue</p></td><td style="width:65pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9"><p class="s26" style="padding-top: 1pt;padding-left: 10pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Lung tissue</p></td></tr><tr style="height:13pt"><td style="width:56pt;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:62pt;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s26" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">(KeV)</p></td><td style="width:69pt;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s26" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">FWHM (mm)</p></td><td style="width:63pt;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s26" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">FWHM (mm)</p></td><td style="width:65pt;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s26" style="padding-left: 10pt;text-indent: 0pt;text-align: left;">FWHM (mm)</p></td></tr><tr style="height:15pt"><td style="width:56pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s67" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">18<span class="s68">f</span></p></td><td style="width:62pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 13pt;text-indent: 0pt;text-align: left;">633</p></td><td style="width:69pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">0.18</p></td><td style="width:63pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">0.19</p></td><td style="width:65pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 10pt;text-indent: 0pt;text-align: left;">0.37</p></td></tr><tr style="height:15pt"><td style="width:56pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s67" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">11<span class="s68">C</span></p></td><td style="width:62pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 13pt;text-indent: 0pt;text-align: left;">959</p></td><td style="width:69pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">0.22</p></td><td style="width:63pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">0.28</p></td><td style="width:65pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 10pt;text-indent: 0pt;text-align: left;">0.52</p></td></tr><tr style="height:15pt"><td style="width:56pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s67" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">13<span class="s68">n</span></p></td><td style="width:62pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">1197</p></td><td style="width:69pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">0.26</p></td><td style="width:63pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">0.33</p></td><td style="width:65pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 10pt;text-indent: 0pt;text-align: left;">0.62</p></td></tr><tr style="height:15pt"><td style="width:56pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s67" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">15<span class="s68">o</span></p></td><td style="width:62pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">1738</p></td><td style="width:69pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">0.33</p></td><td style="width:63pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">0.41</p></td><td style="width:65pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 10pt;text-indent: 0pt;text-align: left;">0.86</p></td></tr><tr style="height:15pt"><td style="width:56pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s67" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">68<span class="s68">Ga</span></p></td><td style="width:62pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">1900</p></td><td style="width:69pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">0.36</p></td><td style="width:63pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">0.49</p></td><td style="width:65pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 10pt;text-indent: 0pt;text-align: left;">0.98</p></td></tr><tr style="height:15pt"><td style="width:56pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s67" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">82<span class="s68">rb</span></p></td><td style="width:62pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">3350</p></td><td style="width:69pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">0.56</p></td><td style="width:63pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">0.76</p></td><td style="width:65pt;border-top-style:solid;border-top-width:1pt;border-top-color:#9B95C9;border-bottom-style:solid;border-bottom-width:1pt;border-bottom-color:#9B95C9"><p class="s27" style="padding-top: 2pt;padding-left: 10pt;text-indent: 0pt;text-align: left;">1.43</p></td></tr></table><p class="s21" style="padding-top: 1pt;padding-left: 9pt;text-indent: 0pt;text-align: justify;">fWHm, full width at half-maximum.</p><p class="s28" style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">2.7.3 <span class="s29">Imaging</span></p><p style="padding-top: 3pt;padding-left: 11pt;text-indent: 0pt;line-height: 94%;text-align: justify;">FDG is phosphorylated intracellularly into FDG-6-phosphate and trapped, taking no further part in the glycolytic pathway, and the image therefore represents a map of glu- cose utilization in the scanned area. Typically scanning is performed at least one hour after intravenous injection, which allows for sufficient FDG uptake to achieve good signal-to-noise ratio for imaging lesions.</p><p style="padding-left: 11pt;text-indent: 8pt;line-height: 94%;text-align: justify;">Modern imaging combines PET with CT to give added topographical information on the distribution of FDG. Initially a full helical CT image set is acquired, then the couch moves into the PET component where individual bed positions, typically about 16 cm in length, are scanned to cover the entire body length required; this may take up to 30 min (Figure 2.9). In fused images the registration accuracy of ~1 mm arises from precise mechanical alignment in scanners. Artefacts arising from respiratory motion and attenuation correction are known pitfalls and can be minimized with experience and by using gating techniques.</p><p style="text-indent: 0pt;text-align: left;"><span><img width="388" height="134" alt="image" src="Image_026.png"/></span></p><p class="s69" style="text-indent: 0pt;line-height: 10pt;text-align: left;">CT</p><p class="s69" style="text-indent: 0pt;line-height: 10pt;text-align: left;">CT</p><p style="text-indent: 0pt;text-align: left;"/><p class="s69" style="text-indent: 0pt;line-height: 10pt;text-align: left;">CT</p><p class="s69" style="text-indent: 0pt;line-height: 10pt;text-align: left;">PET</p><p class="s69" style="text-indent: 0pt;line-height: 10pt;text-align: left;">PET</p><p style="text-indent: 0pt;text-align: left;"/><p class="s69" style="text-indent: 0pt;line-height: 10pt;text-align: left;">PET</p><p class="s70" style="text-indent: 3pt;text-align: left;">FDG ~ 1hr prior to scan</p><p class="s70" style="text-indent: 3pt;text-align: left;">FDG ~ 1hr prior to scan</p><p style="text-indent: 0pt;text-align: left;"/><p class="s70" style="text-indent: 3pt;text-align: left;">FDG ~ 1hr prior to scan</p><p class="s71" style="text-indent: 0pt;line-height: 8pt;text-align: left;">WB ~ 1min</p><p class="s71" style="text-indent: 0pt;line-height: 8pt;text-align: left;">WB ~ 1min</p><p style="text-indent: 0pt;text-align: left;"/><p class="s71" style="text-indent: 0pt;line-height: 8pt;text-align: left;">WB ~ 1min</p><p class="s71" style="text-indent: 0pt;line-height: 8pt;text-align: left;">WB ~ 20min</p><p class="s71" style="text-indent: 0pt;line-height: 8pt;text-align: left;">WB ~ 20min</p><p style="text-indent: 0pt;text-align: left;"/><p class="s71" style="text-indent: 0pt;line-height: 8pt;text-align: left;">WB ~ 20min</p><p style="padding-left: 11pt;text-indent: 8pt;line-height: 94%;text-align: justify;">Malignant cells typically have a higher glucose metabolism compared with normal cells and hence may be identified on PET; however, increased glucose metabolism is not unique to malignancy and hence false positive scans may occur in areas of infec- tion and inflammation. Additional functional information is available by performing kinetic investigations in PET with dynamic scanning techniques.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s72" style="padding-left: 179pt;text-indent: 0pt;line-height: 7pt;text-align: left;"><span><img width="9" height="9" alt="image" src="Image_027.png"/></span>	<span><img width="9" height="9" alt="image" src="Image_028.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="text-indent: 0pt;text-align: left;"><span><img width="234" height="117" alt="image" src="Image_029.jpg"/></span></p><p class="s69" style="text-indent: 0pt;line-height: 10pt;text-align: left;">+</p><p class="s69" style="text-indent: 0pt;line-height: 10pt;text-align: left;">+</p><p style="text-indent: 0pt;text-align: left;"/><p class="s69" style="text-indent: 0pt;line-height: 10pt;text-align: left;">+</p><p class="s69" style="text-indent: 0pt;line-height: 10pt;text-align: left;">=</p><p class="s69" style="text-indent: 0pt;line-height: 10pt;text-align: left;">=</p><p style="text-indent: 0pt;text-align: left;"/><p class="s69" style="text-indent: 0pt;line-height: 10pt;text-align: left;">=</p><p class="s70" style="padding-top: 2pt;padding-left: 176pt;text-indent: 0pt;text-align: left;">CT        PET     FUSED</p><p class="s24" style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;line-height: 117%;text-align: left;">Fig. 2.9 <span class="s25">Clinical Pet/Ct depicting transmission scanning in Ct and emission scanning in Pet leading to fused whole body images.</span></p><p class="s19" style="padding-top: 4pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">2.8 <span class="h4">Imaging in clinical oncology</span></p><p style="padding-top: 4pt;padding-left: 5pt;text-indent: 0pt;line-height: 94%;text-align: justify;">Imaging is an integral part of clinical oncology and continues to play an essential role in the diagnostic and therapeutic pathways of our patients. Over the past few decades, we have seen an evolution in radiotherapy treatment planning from the use of 2D plan- ning to the advent of CT simulators and more recently, the introduction of multileaf collimators and inverse planning, leading to the introduction of intensity-modulated radiotherapy (IMRT) and image-guided radiotherapy (IGRT). These technological ad- vancements have improved tumour control and reduced treatment-related toxicities with the delivery of more focused and targeted radiation. However, these advancements have placed an even greater emphasis on the need of good quality imaging tools to guide radiation therapy. In this section, we will explore the use of imaging in clinical oncology.</p><p class="s28" style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">2.8.1 <span class="s29">Diagnostic role</span></p><p class="s28" style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">2.8.1.1 <span class="s66">Diagnosis</span></p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 94%;text-align: justify;">Tumour biopsy under US or CT guidance are commonly used now as an alternative to more invasive procedures such as bronchoscopy or laparoscopy. However, the ultimate goal is to have an imaging tool that could replace tissue diagnosis. Unfortunately, this is still beyond what the current imaging technology can achieve. Nonetheless, a unique tumour that may be diagnosed based on radiological and clinical features is hepatocellular carcinoma (HCC). A liver tumour which shows the classical imaging features of arterial hypervascularity and venous or delayed phase washout on a back- ground of liver cirrhosis can be diagnosed as HCC without the need for biopsy prior to definitive treatment. However, this does not apply in other tumours. The American College of Radiology has introduced standardized imaging reporting datasets to cat- egorize radiological features into risk categories of increasing malignant potential in breast (Breast Imaging Reporting and Data System [BI-RADS]), prostate (Prostate Imaging Reporting &amp; Data System [PI-RADS]), and liver cancers (Liver Imaging Reporting &amp; Data System [LI-RADS]) in order to help clinicians to identify suspicious tumours for further evaluation.</p><p class="s28" style="padding-top: 6pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">2.8.1.2 <span class="s66">Staging</span></p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 94%;text-align: justify;">Cross-sectional imaging such as CT and MRI are routinely used to diagnose and stage cancers. CT remains the standard staging modality in most cancer types, particularly in less developed countries, due to its widespread availability, ease of access and cost. However, its limited soft tissue contrast makes it less ideal for local tumour (T) staging in certain tumours such as prostate and rectal cancers. In these cancer types, MRI has played an important role in stratifying patients for treatment based on its superior soft tissue characterization for T staging and additional physiological information derived from DCE and diffusion-weighted (DWI) sequences compared to standard CT. In addition to cross-sectional imaging, endoscopic ultrasound (EUS) is also an important tool for tumour staging. EUS has superior T staging accuracy compared to cross-sectional imaging for oesophageal cancer coupled with its ability to sample suspicious lymph nodes. Despite this, EUS is still underutilized in oesophageal staging because of its user dependency and the lack of trained endoscopists.</p><p style="padding-top: 4pt;padding-left: 11pt;text-indent: 8pt;line-height: 94%;text-align: justify;">With regards to nodal and distant tumour staging, <span class="s22">18</span>F-FDG PET/CT is now widely accepted as part of the standard staging pathway for melanoma, lymphoma, head and neck, lung, breast, and upper gastrointestinal cancers. It has improved staging ac- curacy, leading to tumour stage migration which has influenced subsequent patient management and ultimately improved patient survival. In non-small cell lung cancer (NSCLC), <span class="s22">18</span>F-FDG PET has shown superior sensitivity and specificity in mediastinal nodal staging compared to CT. In addition, up to a third of patients with convention- ally staged locally advanced NSCLC initially suitable for radical chemoradiation were found to have occult metastatic disease (20%) and locoregional disease too extensive for radical irradiation (10%) following PET staging.<span class="s22">3 </span>Similar findings were also found in other tumour types.</p><p style="padding-left: 11pt;text-indent: 8pt;line-height: 94%;text-align: justify;">Ideally, all patients should have equal access to the different types of staging modalities but this is not feasible in the real world. Hence, the choice of any imaging modalities in cancer staging will depend on a number of factors such as intent of treatment, afford- ability, ease of access and patient suitability (e.g. presence of contraindications to MRI).</p><p class="s28" style="padding-top: 7pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">2.8.1.3 <span class="s66">Prognosis</span></p><p style="padding-top: 2pt;padding-left: 11pt;text-indent: 0pt;line-height: 94%;text-align: justify;">Imaging may also have a role in risk stratifying and prognosticating patients. The prognostic value of TNM staging, lymphovascular/perineural invasion, and extra- mural/capsular extension is well established. In recent years, there is growing interest to identify additional qualitative and quantitative imaging features that may portend poor prognosis. Functional imaging holds great promise in this regard as it could pro- vide surrogates for aggressive tumour phenotypes, for example cellular metabolism, proliferation, and hypoxia.</p><p style="padding-left: 11pt;text-indent: 8pt;line-height: 90%;text-align: justify;">Pre-treatment <span class="s22">18</span>F-FDG PET parameters such as maximum standardized uptake values (SUV<span class="s36">max</span>) and metabolic tumour volume (MTV) were shown to be associated with overall survival in various cancers including lung, head and neck, oesophageal, pancreatic, endometrial, ovarian, and cervical cancers. Early evidence also suggests that DWI parameters such as apparent diffusion coefficient (ADC) may be associated</p><p style="padding-left: 11pt;text-indent: 0pt;line-height: 94%;text-align: justify;">with aggressive pathological features in prostate, rectal, and gynaecological cancers. However, it is important to remember that most of these findings although promising, cannot be reliably used to direct patient management at present due to unresolved issues regarding standardization of image acquisition and analysis protocols, as well as the unknown impact of intra- and intertumoral heterogeneity.</p><p class="s28" style="padding-top: 10pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">2.8.2 <span class="s29">Therapeutic role</span></p><p class="s28" style="padding-top: 5pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">2.8.2.1 <span class="s66">Tumour volume delineation</span></p><p style="padding-top: 2pt;padding-left: 11pt;text-indent: 0pt;line-height: 94%;text-align: justify;">With the shift from 2D to 3D planning and now IMRT, there is a need to accurately define target volumes and organs at risk (OARs) in order to improve local tumour control and decrease treatment-related toxicities, resulting in a surge of interest in the use of PET and MRI in target volume delineation. <span class="s22">18</span>F-FDG PET has shown potential in improving the contouring accuracy in clinical practice. Its role in lung cancer ra- diation planning has been the most extensively studied, differentiating lung tumours from adjacent atelectasis although experience in other tumour types has also been</p><p style="padding-top: 4pt;padding-left: 5pt;text-indent: 0pt;line-height: 94%;text-align: justify;">reported.<span class="s22">4,6 </span>The use of <span class="s22">18</span>F-FDG PET may significantly alter the treatment volumes compared to the use of planning CT alone. PET may also identify suspicious meta- bolically active mediastinal/supraclavicular nodal disease and is increasingly used in oesophageal, lymphoma, and head and neck radiation planning. In oesophageal cancer, PET is commonly fused with planning CT to assist with the definition of the craniocaudal extent of primary tumours. In lymphoma and head and neck cancers, it is predominantly used for nodal volume delineation. In most head and neck cancers, MRI is commonly fused with the planning CT for primary tumour delineation due to its superior soft tissue definition compared to CT or PET. Most studies have shown that GTV using CT or MR tends to overestimate the actual tumour extent, with <span class="s22">18</span>F- FDG PET-defined GTVs showing the best pathological correlation, although these correlations are modest at best.</p><p style="padding-left: 5pt;text-indent: 8pt;line-height: 94%;text-align: justify;">Furthermore, there are many complexities associated with the use of MRI/<span class="s22">18</span>F-FDG PET in radiation planning which remains CT based. In most cases, these scans are performed at different time points relative to simulation and are not done in the radio- therapy treatment positions which create problems with subsequent co-registration of the diagnostic and simulation images for radiation planning purpose. Rigid image registration using bony anatomy is commonly used in intracranial and prostate can- cers where tumour motion is negligible, but this has limited utility in mobile thoracic or intra-abdominal tumours. Non-rigid or deformable registration, where the pixel- to-pixel relationships within the diagnostic images are changed to adapt to the refer- ence planning CT, was introduced to overcome these issues by improving the mapping of tumour volumes between the two datasets. However, there are limited validation studies to support the routine use of non-rigid registration in clinical practice due to the uncertainties regarding the accuracy of such image deformation algorithms. Where possible, the MRI or PET scans that are used for radiation planning should be performed in the treatment positions, and the interval between these scans and CT simulation should be kept as short as possible.</p><p style="padding-left: 14pt;text-indent: 0pt;line-height: 11pt;text-align: justify;">Hence, although MRI and PET have the potential to help oncologists to better define</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 94%;text-align: justify;">tumour volumes, we should be aware of the limitations associated with each imaging modality and its use in different tumour types. The advances in anatomical and func- tional imaging have huge potential to improve radiotherapy volume delineation when they are used appropriately.</p><p class="s28" style="padding-top: 7pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">2.8.2.2 <span class="s66">Image-guided radiotherapy</span></p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 94%;text-align: justify;">The introduction of cone beam CT (CBCT) on the linear accelerator allows interfraction tumour localization, which greatly increases the precision of radiation delivery and enables hypofractionated treatment in the range of 8–30 Gy per fraction in extracranial sites. This led to the surge in the adoption of stereotactic ablative/body radiotherapy (SABR/SBRT) in various tumour types due to its superior local control and favourable toxicity profile. However, the image quality of CBCTs remains sub- optimal, especially of intra-abdominal or pelvic tumours.</p><p style="padding-left: 5pt;text-indent: 8pt;line-height: 94%;text-align: justify;">In addition, the use of MRI-guided brachytherapy has improved outcomes in cer- vical and prostate cancers.<span class="s22">7,8 </span>This allowed for more refined dose distribution and en- couraged dose escalation to dominant tumours, hence increasing the therapeutic ratio.</p><p style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;line-height: 94%;text-align: justify;">However, widespread adoption of this technique is still limited, particularly in coun- tries with limited resources as it requires rigorous imaging protocols and intensive manpower.</p><p class="s28" style="padding-top: 7pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">2.8.2.3 <span class="s66">Response assessment</span></p><p style="padding-top: 2pt;padding-left: 11pt;text-indent: 0pt;line-height: 12pt;text-align: justify;">A pertinent use of imaging is in the assessment of treatment response following non- surgical therapy. Radical (chemo)radiation is a standard treatment in unresectable or locally advanced lung, head and neck, and upper gastrointestinal cancers. Discerning residual or recurrent tumours from radiation-related CT changes can be difficult. Standardized reporting guidelines such as Response Evaluation Criteria in Solid Tumours (RECIST) was established to provide a reproducible objective quan- titative volumetric assessment to evaluate treatment response. In those with sus- picious CT findings, the use of follow-up <span class="s22">18</span>F-FDG PET has helped oncologists to identify patients for salvage therapy. Significant FDG uptake in treated tumours will raise suspicion of residual or recurrent disease, provided that there is an adequate interval between the end of radiation and PET scan (typically at least 3–6 months, with improved accuracy as the interval increases). Similarly, PET Response Criteria in Solid Tumours (PERCIST) is also used to quantify changes in SUV<span class="s36">peak </span>for response assessment.</p><p style="padding-left: 11pt;text-indent: 8pt;line-height: 94%;text-align: justify;">Early interim <span class="s22">18</span>F-FDG PET has been shown to have prognostic value in oesophageal cancer and lymphoma treated with chemotherapy. This identifies early non-responders for treatment intensification or triggers a switch in therapy. In contrast, a watch and wait strategy is an attractive option as it allows patients with complete response to avoid the morbidities of surgery and is currently being evaluated in rectal cancer and N2/N3 nodal metastases in head and neck cancers. This strategy requires intensive imaging follow-up to detect disease relapse early to allow timely salvage treatment without compromising on survival.</p><p style="padding-left: 11pt;text-indent: 8pt;line-height: 87%;text-align: justify;">Identification of patients at risk of radiation toxicities is still an evolving field. Pre- treatment <span class="s22">18</span>F-FDG PET uptake in normal lungs (SUV<span class="s36">95</span>) is postulated to predict for risk of radiation pneumonitis in NSCLC and oesophageal cancer.<span class="s22">9,10</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s19" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">2.9 <span class="h4">Future directions</span></p><p style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;line-height: 94%;text-align: justify;">Imaging will continue to play an important role in the practice of clinical oncology. Technological advances in imaging hardware and software will increase its utility in cancer management, with strong emphasis in functional imaging that offers glimpses of <i>in vivo </i>intratumoral physiology which are also targets of novel therapies. MRI/PET simulators and MRI-linear accelerators are now available and may soon be ready for clinical use. This will improve tumour delineation and localization, and ultimately treatment outcomes. Last but not least, intertumoral genetic heterogeneity is well established which may affect the intrinsic tumour radiosensitivity. Imaging has the ability to assess intertumoral phenotypic heterogeneity in a non-invasive manner. The combination of genomics and radiological features termed ‘radiogenomics’ has poten- tial to improve clinical decision making and patient outcomes.</p><p class="s73" style="padding-top: 4pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">References</p><p class="s74" style="padding-top: 5pt;padding-left: 20pt;text-indent: -9pt;text-align: left;">1. <b>European Commission (1999)</b>. <i>European Guidelines on Quality Criteria for Computed Tomography. EUR 16262 EN</i>. Luxembourg: Office for Official Publications for the European Communities.</p><p class="s74" style="padding-top: 1pt;padding-left: 20pt;text-indent: -9pt;text-align: left;">2. <b>Shrimpton PC</b>, <b>Hillier MC</b>, <b>Lewis MA, et al. </b>(2003). <i>Doses from Computed Tomography (CT) Examinations in the UK 2003 review. NRPB-W67. </i>Chiltern: National Radiation Protection Board, UK.</p><p class="s74" style="padding-top: 1pt;padding-left: 20pt;text-indent: -9pt;text-align: left;">3. <b>MacManus MP</b>, <b>Hicks RJ</b>, <b>Ball DL, et al. </b>(2001). F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with non-small cell lung carcinoma: powerful correlation with survival and high impact on treatment. <i>Cancer</i>. <b>92</b>(4): 886–895.</p><p class="s74" style="padding-top: 1pt;padding-left: 20pt;text-indent: -9pt;text-align: left;">4. <b>Konert T, Vogel W, MacManus MP, et al. </b>(2015). PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014. <i>Radiother Oncol. </i><b>116(1)</b>: 27–34.</p><p class="s74" style="padding-top: 1pt;padding-left: 20pt;text-indent: -9pt;text-align: left;">5. <b>MacManus M</b>, <b>Nestle U</b>, <b>Rosenzweig KE, et al. </b>(2009). Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006–2007. <i>Radiotherapy and Oncology</i>. <b>91</b>(1): 85–94.</p><p class="s74" style="padding-top: 1pt;padding-left: 20pt;text-indent: -9pt;text-align: left;">6. <b>Even AJG, van der Stoep J, Zegers CML, et al. (2015). </b>PET-based dose painting in non- small cell lung cancer: Comparing uniform dose escalation with boosting hypoxic and metabolically active sub-volumes. <i>Radiother Oncol. </i>116(2): 281–6.</p><p class="s74" style="padding-top: 1pt;padding-left: 20pt;text-indent: -9pt;text-align: left;">7. <b>Albert JM</b>, <b>Swanson DA</b>, <b>Pugh TJ, et al. </b>(2013). Magnetic resonance imaging-based treatment planning for prostate brachytherapy. <i>Brachytherapy</i>. <b>12</b>(1): 30–37.</p><p class="s74" style="padding-top: 1pt;padding-left: 20pt;text-indent: -9pt;text-align: left;">8. <b>Tanderup K, Viswanathan AN, Kirisits C, Frank SJ. </b>(2014). Magnetic resonance image guided brachytherapy. <i>Semin Radiat Oncol. </i><b>24(3): </b>181–91.</p><p class="s74" style="padding-top: 1pt;padding-left: 20pt;text-indent: -9pt;text-align: left;">9. <b>Petit SF, van Elmpt WJC, Oberije CJG, et al. </b>(2011). [18F]fluorodeoxyglucose uptake patterns in lung before radiotherapy identify areas more susceptible to radiation-induced lung toxicity in non small-cell lung cancer patients. <i>Int J Radiat Oncol. </i><b>81(3): </b>698–705.</p><p class="s74" style="padding-top: 1pt;padding-left: 20pt;text-indent: -13pt;text-align: left;">10. <b>Castillo R, Pham N, Castillo E, et al. </b>(2015). Pre-radiation therapy fluorine 18 fluorodeoxyglucose PET helps identify patients with esophageal cancer at high risk for radiation pneumonitis. <i>Radiology. </i><b>275(3): </b>822–31.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s77" style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Additional resource</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 11pt;text-align: left;"><a href="http://www.CTisus.org/" class="a" target="_blank">Information on specific CT scanning protocols can be found on websites such as </a><a href="http://www.CTisus.org/" target="_blank">http://www.</a></p><p class="s74" style="padding-left: 18pt;text-indent: 0pt;line-height: 11pt;text-align: left;">CTisus.org.</p><p class="nav">&nbsp;&nbsp;</p><p class="nav">&nbsp;</p><p class="nav"><a href="part7.htm">&lt; Назад</a><span> | </span><a href="../index.html">Содержимое</a><span> | </span><a href="part9.htm">Далее &gt;</a></p><p class="nav">&nbsp;&nbsp;</p></body></html>
